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Abstract 
 
Cancer cachexia negatively impacts patients’ capability to undergo chemotherapy 
and fight infection. Increased energy expenditure and anorexia are key clinical 
features among cachexia patients leading to body weight loss. Therefore, it is 
imperative to assess all cancer patients for early signs of undernourishment. 
Nutrition intervention with counselling may ameliorate undernutrition and metabolic 
alterations. The aim of this study was to attenuate the progression to refractory 
cachexia, improve nutritional status and quality of life of female palliative care 
patients by providing nutrient rich natural food along with counselling. Female 
cancer patients with symptoms of cachexia were randomly distributed into control 
and intervention group. Patients were recruited from the Palliative clinic, Oncology 
department in AIIMS, New Delhi, India; control/placebo groups (for pilot n= 30 and 
scale-up n=75) and intervention groups (for pilot n= 33 and scale-up n=75). In 
addition to nutritional and physical activity counselling, intervention patients were 
instructed to consume 100g nutritional supplement (IAtta) on a daily basis with their 
normal dietary intake for a six month period, during the pilot study. Moreover, during 
the scale-up study, the intervention group received 100g of IAtta while the placebo 
group received 100g of whole wheat flour for daily consumption. Anthropometric 
measurements, physical activity level (PAL), dietary intake, quality of life (QoL) and 
biochemical indices were assessed at baseline, three-month and after six-month 
period. Study variables were analysed using repeated-measures ANOVA and the 
Friedman test for multi–comparisons to determine the changes within the groups at 
different time points (i.e. baseline, mid-intervention and post-intervention). Student t-
test/ Wilcoxon ranksum tests were performed on the variables to assess the 
difference between the intervention and control/placebo groups at baseline (P- 
value ≤0.05; 95% confidence interval). After six months, patients in intervention 
group (IAtta group) had significant improvement in PAL (p<0.001) and QoL domain 
(global health status, p<0.001 and fatigue, p=0.001). Conversely, the QoL in the 
placebo group did not improve (global health status, p=0.74) nor did PAL (p=0.49). 
Body mass index was maintained in both groups (IAtta, p-value 0.121; Placebo, p-
value 0.35). Serum albumin levels were significantly reduced (p = 0.005) in placebo 
group patients after six months of intervention.  
ii 
 
Nutrition sensitive intervention (IAtta meal) along with counselling (tailored nutrition 
and physical activity) improves quality of life and nutritional status as well as delays 
progression of cachexia among female palliative care patients. These findings 
highlight the need to ascertain the nutritional status of cancer patients and underpin 
the pivotal role of IAtta as intervention tool to compensate for deficient nutrients. It is 
therefore suggested to embed IAtta into the Indian palliative care framework to 
modulate cancer progression. 
Keywords: cancer cachexia; palliative care; IAtta; quality of life; nutrition sensitive 
intervention    
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Chapter 1:  
 
Introduction 
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1.1 Cancer epidemiology in India  
 
The International Agency for Research on Cancer (GLOBOCAN project, 2012) 
reported approximately 14.1 million new cancer cases and 8.2 million cancer deaths 
worldwide. Out of these there were a little over 1 million cancer cases and 683,000 
cancer deaths in India (Ferlay et al., 2012). The average incidence of cancer 
worldwide (in age adjusted terms) is 182 per 100,000 people and the incidence in 
India is slightly more than the half of the world average (i.e. 94 per 100,000 people) 
(Mallath et al., 2014). The prevalence of cancer at any given point of time in India is 
about 2.5 million patients (Nandakumar, 2009). Cancer registries account for just 
7% of disease prevalence in India however provide the best information to design 
healthcare expenditures. Though higher cancer incidence is reported from the urban 
parts of India, the mortality rate is similar in urban and rural parts suggesting that 
incidence reporting is lower in the rural parts (Goss et al., 2014). The cancer burden 
in India has been predicted to double in the next two decades, to more than 1.7 
million new cases by 2035 and 1.2 million cancer deaths (Ferlay et al., 2012) 
(Figure 1.1-1).  
 
According to the Indian Population Based Cancer Registries, 174,693 cases were 
registered from 2012 to 2014 (National Cancer Registry Programme, 2016). Among 
all Indian states, Delhi registered the highest number of cancer incidence cases, 
19,746 (10,148 males and 9,598 females) (Figure 1.1-2a and 2b). Male patients 
under the age group 15 to 19 years old (10.23%) and 20 to 24 years old (10.58%) 
while female patients under the age group 20 to 24 years old (10.48%) and 25 to 29 
years old (10.18%) were most affected by cancer in Delhi (Figure 1.1-3). Cancers of 
the mouth, lung, stomach, oesophagus, cervix uteri and breast affect majority of the 
Indian population. Among Indian males, cancers of lung, mouth, oesophagus and 
stomach are most common and breast and cervical cancer in females (Figure 1.1-4) 
(National Cancer Registry Programme, 2016).  
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Figure 1.1-1. Predicted cancer prevalence levels in India (Ferlay et al., 2012). 
 
 
 
a): Cancer incidence rates among males                  
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b): Cancer incidence rates among females  
 Figure 1.1-2: Age adjusted cancer incidence rates among males and females 
according to Indian city they reside (National Cancer Registry Programme, 2016).  
 
Figure 1.1-3: Cancer distribution among males and females according to age in Delhi 
(National Cancer Registry Programme, 2016) 
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Figure 1.1-4: Cancer site distribution among males and females in Delhi (National 
Cancer Registry Programme, 2016)  
In spite of being the second most populated country in the world, only 3.9% of 
countries GDP is spent on health care in India. Almost two-thirds of the Indian 
cancer patients belong to either low or upper-lower socioeconomic strata (Goss et 
al., 2014). Although majority of the population resides in rural parts, 95% of cancer 
care providers are established in urban parts (Banavali, 2015). Around 80% of 
Indian cancer patients are diagnosed when the disease has progressed to an 
incurable metastatic stage (Fox et al., 2015). Advanced cancer patients face a big 
economic burden due to the disease prognosis and treatment. Patients undergoing 
radiotherapy (with or without chemotherapy) spend on an average of 60% of their 
weekly income towards treatment expenses. India is suffering from a great shortage 
of health-care providers, data shows that there is just one oncologist per 16000 
cancer patients and an availability of 12 healthcare workers per 10,000 population 
(poor compared to World Health Organisation (WHO) guidelines of 25) (Goss et al., 
2014). 
 
 The accessibility of reliable cancer treatment is very limited for most Indians 
(Maroju et al., 2011, p134). Palliative care is a developing field in the Indian national 
healthcare system. Numbers of palliative care centres are increasing (908 centres) 
and assistance from trained hospital staff is available, but still there is a vast gap 
owing to the high incidence of cancer (Suhag et al., 2015; Ministry of Health and 
Family Welfare, 2012). 
 
Nutrition is considered an important element of palliative care. Patients’ nutritional 
management continues throughout palliative treatment span, in order to enhance 
Nutrition Intervention in Indian Cancer   Chapter 1 
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their quality of life and nutritional status (Richardson and Davidson, 2015, p 191). 
Sadly in Indian palliative care system, nutritional assessment is not practiced by 
treating physicians and dietician/ nutritionist support is only available for hospitalized 
oncology in-patients. Indian palliative care guidelines include prescription of dietary 
supplements in advanced cancer patients to ensure nutritional status management. 
Commercial dietary supplements (Prosure, Ensure, Resource and Fresubin) are 
mostly available at urban pharmacy outlets, making it inaccessible (perhaps 
unaffordable) for the rural patients. Therefore, there is a need to develop 
sustainable natural food based nutritional supplement using locally available secure 
ingredients. Palliative care services should consider developing simple care 
guidelines (that embed adequate nutrition) to empower family members and 
caregivers for optimum patient management in the household setting. 
 
Undernutrition results in delayed response to therapy among cancer patients, low 
quality of life, higher healthcare cost and poor survival rate (Lee et al., 2016). 
Therefore, nutritional intervention can result in favourable treatment response 
among advanced cancer patients who receive palliative chemotherapy and/or 
radiotherapy.   
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1.2 Research hypothesis, aims and objectives 
 
1.2.1 Research hypothesis 
 
We hypothesize that: 
- Improved Atta supplementation (Tailored food recipe-TFR) along with nutritional 
counselling can enhance female cancer cachexic patients’ nutritional status and 
quality of life. 
- Supplementation with TFR (Improved Atta-IAtta) can delay the progression of 
cancer cachexia to refractory cachexia.  
 
1.2.2 Aim 
 
To assess the effectiveness of tailored food recipe (IAtta) in delaying the 
progression of cachexia to refractory cachexia in adult female cancer patients. 
 
1.2.3 Objectives 
 
The objectives of the study were:  
1. To design and optimise a nutritional food recipe (IAtta) for intervention and to 
ascertain its macro and micronutrient contents. 
2. To estimate the nutritional intake of free-living female cancer cachexia 
patients (baseline data). 
3. To appraise the qualitative and quantitative outcomes of ‘IAtta’ on the health 
status of free-living cancer cachexia patients (at baseline versus end point) 
via pilot and scale-up interventions. 
4. To evaluate the nutritional role of IAtta in Indian palliative care framework in 
delaying the progression of cachexia to refractory cachexia in cancer 
patients. 
 
 
 
   8 
 
 
 
 
 
 
 
 
 
 
Chapter 2: 
 
Review of Literature  
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2.1 Cancer cachexia and classification 
 
The word cachexia is derived from the Greek words kakos meaning bad and hexis 
meaning state of being or condition, and is a common feature of several advanced 
diseases such as acquired immunodeficiency syndrome, cancer and congestive 
heart failure (Argiles et al., 2004). Cancer cachexia has been documented as a 
recurrent problem and a major reason of morbidity and mortality amongst cancer 
patients. Worldwide, more than 50-80% of advanced cancer patients suffer from 
cachexia, and it accounts for mortality in 20% of them (Argiles et al., 2014). Few 
tumour sites are widely associated with cachexia (like pancreatic, gastric, head and 
neck) but the same tumour site may exhibit cachexia of varying degree or be absent 
in different patients (Tisdale, 2009). The prevalence of cancer cachexia in India is 
not available for documentation. 
 
Cancer cachexia can be described as “a multifactorial syndrome defined by an 
ongoing loss of skeletal muscle mass (with or without loss of fat mass) that cannot 
be fully reversed by conventional nutritional support and leads to progressive 
functional impairment. Its pathophysiology is characterised by a negative protein 
and energy balance driven by a variable combination of reduced food intake and 
abnormal metabolism” (Fearon et al., 2011).   
 
Weight loss in cachexia is due to wasting of skeletal muscle as well as adipose 
tissue. In skeletal muscle, due to protein breakdown amino acids are generated, 
which thereby contribute to fuel hepatic protein and glucose synthesis (Tisdale, 
2002). Reduced immunity and mobility are results of skeletal muscle wasting 
(MacDonald et al., 2003). As weight loss advances to 30% of pre-treatment body 
weight, death becomes inevitable (Tisdale, 2004). Cachexia negatively impacts 
patients’ capability to endure chemotherapy and fight infection (Theologides, 1979). 
Increased energy expenditure and anorexia are key factors among cachexia 
patients leading to weight loss (Young, 1977; Dhanapal et al., 2011) (Figure 2.1-1). 
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Figure 2.1-1: Cancer cachexia and physiological outcomes (Dodson et al., 2011).  
 
Cancer cachexia is classified into three stages: precachexia, cachexia and 
refractory cachexia (Figure 2.1-2). Involuntary weight loss (≤5% pre-treatment) due 
to metabolic changes and symptoms like anorexia is classified as pre-cachexia 
stage. Degree of progression depends upon cancer site, stage, degree of 
inflammation, nutritional status and response to anticancer treatment. Patients with 
more than 5% of body weight loss over a six month period or body mass index 
(BMI) less than 20 Kg/m2 and/or sarcopenia will be classified under cachexia stage. 
When patients fail to respond to anticancer therapy with progressive disease 
leading towards a catabolic stage with continued weight loss, they are classified into 
refractory cachexia stage. Except for symptom management, no intervention is 
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advised during refractory cachexia and a survival period of less than three months is 
expected (Fearon et al., 2011).  
 
 
Figure 2.1-2: Classification of cancer cachexia (Fearon et al., 2011). 
 
2.2 Diagnosis of cancer cachexia 
 
Cancer cachexia is a multifactorial syndrome with ongoing metabolic changes 
making its diagnosis challenging. In 2006, Fearon et al., documented a three factor 
classification to identify cancer patients suffering from cachexia. Advanced cancer 
patients experiencing any two of the symptoms of, weight loss of more than 10% 
compared to their pre-treatment body weight, total calorie intake of less than1500 
kcal per day or systemic inflammation determined by C-reactive protein level (more 
than10 mg/l) were diagnosed with cachexia. While in 2011, a panel of cachexia 
experts agreed on a common definition and a classification for cancer cachexia. 
According to the new classification patients experiencing weight loss of more than 
5% over past six months, compared to their pre-treatment body weight, or body 
mass index (BMI) of less than 20Kg/m2 with continuing weight loss of more than 2% 
or presence of sarcopenia, are classified as cachectic. Assessment should also 
include percentage of weight loss, muscle mass, anorexia or appetite loss, reduced 
food intake, inflammation levels and psychosocial impact (Fearon et al., 2011). 
 
The European Palliative Care Research Collaborative (EPCRC) cancer cachexia 
guidelines for advanced cancer patients, suggests the following parameters should 
be assessed (Radbruch et al., 2010):  
 
1. History: Weight change, speed of weight loss, percentage of normal intake. 
2. Clinical examination: Body weight, physical strength. 
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3. Laboratory examination: C - reactive protein (CRP), blood glucose profile. 
4. Activity monitoring: Upper limb hand-grip dynamometry, performance status. 
5. Body composition: anthropometry (mid-arm muscle area), bioelectrical 
impedance analysis (BIA). 
 
Weight loss can be assessed by comparing patients’ current body weight to their 
pre-treatment weight using medical records. Increased weight loss is associated 
with poor therapy outcomes and along with BMI can help in prediction of overall 
survival (Martin et al., 2015). To measure muscle mass computed tomography (CT) 
cross-sectional imaging, magnetic resonance imaging (MRI), dual energy x-ray 
(DEXA) imaging, anthropometry (mid-arm muscle area) and BIA can be used. 
Muscle depletion is associated with functional impairment and reduced survival rate 
prediction among cachexic patients. Reduced food intake assessment will require 
patients’ dietary recall using food diaries and food frequency questionnaires 
undertaken by a trained dietician. This includes quantification of macronutrient and 
micronutrient intake to identify specific nutrient deficiencies. Appetite loss and 
anorexia can be determined employing malnutrition questionnaires like PG- SGA 
(Patient Generated-Subjective Global Assessment), MNA (Mini-Nutritional 
Assessment), MST (Malnutrition Screening Tool) and MUST (Malnutrition Universal 
Screening Tool) during patient interaction sessions. Intake data and anorexia 
assessment will help the practitioner recognize the underlying causes (like nausea, 
stomatits, mucositis, diarrhoea, constipation) contributing to reduced food 
consumption. Among inflammation markers, C-reactive protein (CRP) is the most 
widely accepted marker and modified Glasgow Prognostic score (mGPS) is the 
most acceptable scale. Inflammation impacts survival and cancer related symptoms. 
European Organisation for Research and Treatment of Cancer (EORTC) Quality of 
Life Questionnaire (QLQ)-C30 can estimate patients psychological and social 
functioning (Fearon et al., 2011; Martin, 2016). 
 
2.3 Pathophysiology of cancer cachexia 
 
Nutritional status of patients suffering from cachexia is negatively impacted due to 
tumour induced alterations in metabolism during cancer (DeWys, 1986). Pro-
cachectic factors including proteolysis inducing factor (PIF) and lipid mobilizing 
factor (LMF) are produced by the tumour cells whilst the production of pro-
inflammatory cytokines such as tumour necrosis factor alpha (TNF-α), interleukin - 1 
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(IL-1), interleukin – 6 (IL-6) and interferon –gamma (IFN-у) are the hosts’ 
inflammatory tumour presence response. The cytokines are released by the 
lymphocytes and macrophages of the host immune system. Serum cytokines TNF-
α, IL-1 and IL-6 levels correlate with progression of a few tumours. These cytokines 
inhibit lipoprotein lipase, which in turn restricts fatty acid storage by adipocytes. LMF 
production promotes lipid breakdown from body fat stores (Tisdale, 2009). TNF-α, 
IL-1, IL-6 and IFN-у have been shown to activate cancer induced muscle wasting. 
PIF and pro-inflammatory cytokines lead to protein breakdown by activating the ATP 
ubiquitin-proteasome proteolytic pathway contributing to muscle atrophy (Acharyya 
and Guttridge, 2007). During cancer cachexia, reduction in muscle protein synthesis 
is related to elevated levels of serum PIF. The body’s response to cytokine-derived 
inflammation is called acute phase protein response (APPR). Increased resting 
energy expenditure is due to extended APPR which further leads to weight loss. 
During APPR, protein synthesis in the liver is altered as albumin production is 
substituted by C-reactive protein (CRP), fibrinogen, serum amyloid A, 2-
macroglobulin and α-1 antitrypsin production. Released cytokines TNF-α and IL-1 
are responsible for loss of appetite and anorexia. Disease progression influences 
hypothalamus functioning. The cytokines act upon the hypothalamic areas of the 
brain which control food intake. As fat stores are reduced during cachexia, serum 
leptin levels decrease which lead to suppression of appetite. IL-1 affects food intake 
by reducing neuropeptide-Y levels (appetite stimulant) in the hypothalamus (Tisdale, 
2009). Cachexia, therefore is related to a set of cytokines and other cachectic 
factors responsible for wasting. Imbalance between protein catabolism and 
anabolism aids muscle wasting during cachexia syndrome (Figure 2.3-1). 
 
 
Figure 2.3-1: Pathogenesis of cancer cachexia (Gordon et al., 2005). 
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Hypercatabolism as a result of systemic inflammation can be measured by 
assessing serum CRP levels. Serum CRP levels have been correlated to rate of 
weight loss, onset of cachexia and progression of cancer. Elevated CRP levels 
(>80mg/L) have been associated with increased mortality risk among cancer 
patients (Suzuki et al., 2013).  
 
Modified Glasgow prognostic score (mGPS) is a cancer prognostic marker 
composed of CRP and serum albumin levels. According to mGPS, patients with 
elevated CRP (>10mg/L) are allocated score of 1, while those with both 
hypoalbuminemia (serum albumin < 35g/L) and raised CRP are allocated a score of 
2 (Table 2.3-1). mGPS is associated with length of survival, skeletal mass index, 
weight loss, dietary intake, performance score and treatment complications 
(McMillan, 2013).   
 
Table 2.3-1: Modified Glasgow prognostic scores (mGPS) 
mGPS Points allocated 
CRP (≤10mg/L) and serum albumin (≥ 
35g/L) 
0 
Elevated CRP (>10mg/L) 1 
Elevated CRP (>10mg/L) and 
hypoalbumenia (serum albumin 
<35g/L) 
2 
 
 2.4 Malnutrition and assessment among 
advanced cancer patients 
 
Malnutrition is prevalent in 40%- 80% of oncology patients worldwide (Paccagnella 
et al., 2011; Kumar et al., 2010). Multiple factors lead to malnutrition among cancer 
patients, such as disease progression, therapy side-effects like altered taste 
perception and emotional changes. Malnutrition results in delayed response to 
therapy among cancer patients, low quality of life, higher healthcare cost and poor 
survival rate (Lee et al., 2016). Head and neck cancer patients in eastern part of 
India have reported high prevalence of malnutrition (76.9%), as well as over 80% of 
gynaecological cancer patients in western part. (Bhattacharjee et al., 2015; Das et 
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al., 2014). Among advanced cancer patients malnutrition is a strong predictor of 
morbidity (Lis et al., 2012) (Figure 2.4-1). 
 
 
Figure 2.4-1: Flowchart showing mutual relationships between malnutrition, cancer 
and clinical outcome (adapted from Henry, 2011, p 65). 
 
Body mass index (BMI) less than 20Kg/m2 is a marker for undernutrition. Presence 
of oedema or ascites should be assessed before interpreting patient BMI as it may 
mask the presence of undernutrition, by an increased body weight due to water 
retention. Upper arm anthropometry is an easy clinical tool to measure skeletal 
muscle store and has been documented to be less prone to oedema (Richardson 
and Davidson, 2015, p.194). Sarcopenia (depletion of skeletal muscle) is diagnosed 
according to established cut-off points (below the 5th percentile for healthy adults). 
Cancer effects of the 
tumour (local effect, 
production of 
cytokines, effect of 
anticancer therapy) 
Complications 
Increased length of 
stay 
Decreased quality 
of life 
Increased costs 
Malnutrition 
 
Increased mortality 
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Using anthropometry, upper-arm muscle area, sarcopenia is identified in men with 
measurement less than 32cm2 and in women less than 18cm2. By DEXA, 
appendicular skeletal muscle index in sarcopenia in men is less than 7.26Kg/m2 and 
in women it is less than 5.45Kg/m2. Using BIA, sarcopenia can be defined by whole 
body fat-free level of less than 14.6Kg/m2 in men and in women less than 
11.4Kg/m2. With the help of CT imaging, lumbar skeletal muscle index of less than 
55cm2/m2 in men and less than 39cm2/m2 is categorized as sarcopenia (Fearon et 
al., 2011). 
 
Prognostic Nutritional Index (PNI) and Nutritional Assessment Index (NAI) are 
widely used in oncology settings among adults to identify risk of malnutrition 
(Bhatacharjee et al., 2015). Patient-generated subjective global assessment (PG-
SGA) is a nutrition status assessment tool based on the dietary intake, weight 
change, functional ability, symptoms and physical observation validated for use in 
cancer patients. On assessment, patients are categorized as well-nourished, 
moderately malnourished or severely malnourished. A numerical PG-SGA score is 
calculated, with higher scores indicative of nutritional status decline (Ottery,1996). 
 
Serum albumin is a protein marker and an indicator of amount of lean muscle 
tissue. It is commonly used to assess patient nutritional status and disease 
progression. As cancer progresses, patients nutritional status deteriorates and 
inflammation increases which leads to suppression in albumin synthesis (Gupta and 
Lis, 2010). 
 
Among oncology patients, undernutrition is often overlooked, despite its high 
prevalence relationship with treatment outcomes. It should be addressed at the 
earliest opportunity with the help of dietician assessing malnutrition stage, 
counselling session to design an individualized nutritional plan according to their 
food pattern and introducing ONS (Oral Nutrition Supplement) intake daily in 
addition to normal diet if required. Consulting healthcare professionals should also 
provide encouragement to the patient, supporting their dietary changes (Lee et al., 
2016). 
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2.5 Symptoms due to disease progression and 
anti-cancer treatments in advanced cancer  
 
Symptom management has an impact on patients’ quality of life and their nutritional 
status. Optimal symptom management and maintaining patients’ independent 
functionality should be the main focus of the palliative therapist.  
  
Fatigue is commonly reported among chemotherapy and radiotherapy patients. 
Fatigue is present along with other symptoms like anorexia, nausea, vomiting, 
dyspnoea, insomnia, anxiety and depression (Yennurajalingam and Bruera, 2015, p. 
410). Free-living advanced cancer patients reported significant association between 
fatigue, anorexia and anxiety (Rhondali et al., 2012). 
 
Changes in food preferences and decline in food intake causes emotional strain 
between advanced cancer patients and caregivers. Female caregivers express their 
care for the patient by preparing and serving food. Family members feel rejected by 
the patient when food is refused. Unnecessary pressure on patient to consume food 
sometimes becomes a barrier to food intake (Amano et al., 2016).  
 
Cachexic patients frequently experience muscle weakness which leads to increased 
dependence on the caregiver for basic day-to-day activities. These patients 
experience psychological distress in the form of anger, frustration, uncertainty, fear, 
desperation and helplessness. They suffer from social loneliness due to wasted 
appearance and inability to consume their food (Cooper et al., 2015).        
 
Cancer patients experience chronic pain and opioid therapy is recommended. 
Opioid induced constipation has been reported by 40% - 80% cancer chronic pain 
patients on morphine therapy. Constipation negatively affects patients’ quality of life 
(Datto et al., 2016). Opioids such as morphine have significant effects on the 
reticular system and are capable of inducing sedation, cognitive changes, and 
fatigue in some patients. In addition, anxiolytics, hypnotics, and other drugs may 
cause sedation and fatigue (Yennurajalingam and Bruera, 2015, p. 420). The most 
common opioid-related adverse effects include constipation, sedation, confusion, 
and hallucinations (Alexander et al., 2016). 
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2.5.1Chemotherapy and radiotherapy as cancer medical 
treatment 
 
Anti-cancer treatments like chemotherapy and radiotherapy have a negative impact 
on patients’ nutritional intake. Chemotherapy drugs are known to induce 
gastrointestinal difficulties like nausea, vomiting and anorexia leading to a decrease 
in the quality of life. Patients undergoing radiotherapy (depending on treatment site) 
experience several side effects. Head and neck cancer patients receiving 
radiotherapy suffer from anorexia, ulceration, xerostomia, mucositis and 
hypogeusia, while abdomen and pelvis cancer patients experience anorexia, 
nausea, ulceration, vomiting, diarrhea and enteritis post radiotherapy. These 
symptoms therefore hinder maintenance of patients’ nutritional status (Suzuki et al., 
2013). 
 
Immunosuppression among cancer patients due to disease or therapy increases 
their risk of infections and recovery time. In patients with cancer, myelosuppression 
due to therapy drugs, excessive bleeding, nutritional deficiency and haemolysis 
leads to anaemia (Yennurajalingam and Bruera , 2015, p. 416). 
 
2.6 Nutritional requirements of advanced 
cancer patients 
 
Palliative patients frequently complain of early satiety on consumption of low gastric 
volume foods. Along with low functional ability, their hunger is lost and diminishes 
nutrient utilization (Richardson and Davidson, 2015, p. 195). 
   
Kumar et al., (2010) observed a calorie deficit of approximately 250-400 kcal/d 
among weight losing patients suffering from cancer cachexia. To replete or stabilize 
skeletal muscle wasting it is advised to maintain protein intake between 1-
1.5g/Kg/day (Baracos et al., 2015, p.712).  
 
Research has shown that weight maintenance can be attained at 34kcal/Kg body 
weight/d (Lundholm et al., 2004), another intervention study has documented that 
weight stabilisation can be achieved at energy intake of 28.7kcal/Kg body weight/d 
and protein intake of 1.4g/Kg body weight/d (Bauer and Capra, 2005). Increased 
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calorie intake by oral nutritional supplements or enteral feeds in patients undergoing 
oncological treatment has resulted in decreased incidence of complications. 
(Bozzetti and Mori, 2009). 
 
According to recommendations for cancer patients undergoing chemoradiotherapy 
by the French Speaking Society of Clinical Nutrition and Metabolism, all patients 
should undergo nutritional assessment using PG-SGA malnutrition tool at each visit. 
Undernourished or at-risk patients are recommended to visit nutritional experts and 
receive counselling session. ONS can be prescribed if necessary. Dietary planning 
should fulfil energy requirements of 30–35 kcal/Kg/d and protein of 1.2–1.5 g/Kg/d 
(Senesse et al., 2014). A recent paper by the Italian Society of Medical Oncology 
suggested that malnutrition among oncology patients should be treated at priority 
level with structured recommendations from oncologists and nutrition experts. The 
main aim of nutritional support should be to compensate deficient nutrient intake 
and improve nutritional status as well as clinical outcomes for every malnourished 
cancer patient (Caccialanza et al., 2016).  
 
Physical activity is recommended in the management of cancer cachexia. It may 
boost the immune function and improve quality of life (Ardies, 2002; Radbruch et al., 
2010). There are no specific nutritional and physical activity requirements drafted for 
Indian advanced cancer patients.  
 
Dietary assessment and tailored nutrition advice from a trained dietician can benefit 
weight losing cachexic patients (Baracos et al., 2015, p.712). 
 
2.7 Multimodal therapy treatment for cancer 
cachexia 
 
 
A multimodal therapy approach is considered the most effective for management of 
cachexia patients. This involves nutritional support (oral nutritional supplement 
intake), oncological management, anti-inflammatory and anaemia therapy, 
encouraging physical activity, and multidisciplinary team work approach in order to 
improve health status of the patient (Fearon, 2008) (Figure 2.7-1). 
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Figure 2.7-1: Multimodal rehabilitation for cancer cachexia (Fearon, 2008). 
An individualised treatment approach using a combination of pharmacological and 
non-pharmacological interventions should be planned for cachexic patients. Expert 
inputs from a team of dieticians, occupational therapists, psychologists, social 
workers and nurses in addition to treating oncologist and palliative physician will 
optimally benefit the cachexic patient. Exercise, nutritional, anti-inflammatory and 
anti-cancer treatments form the basic components of multimodal cachexia therapy 
(Del Fabbro, 2015).  
 
 A randomized controlled trial incorporated five different arms of treatment including 
progestational agent in arm one, oral nutritional supplement including EPA in arm 
two, L- carnitine in arm three, Thalidomide as arm four for its anti-inflammatory 
property and arm five was a combination of all the four arms. Patients belonging to 
arm five after four months of treatment performed the best. These patients reported 
significant increase in their lean body mass, reduction in resting energy expenditure 
(REE), improvement in appetite and performance status compared to patients of 
arm 1, 2, 3 and 4 (Mantovani et al., 2010). Multimodal therapy intervention was 
more effective among advanced gynaecological cancer patients than megestrol 
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acetate intervention. Patients receiving multimodal therapy for four months reported 
better QoL and reduced inflammation and oxidative stress than the group receiving 
megestrol acetate (Maccio et al., 2012). A review by Madeddu et al., (2012) 
concluded that multimodal intervention is more effective than individual drug or 
supplement approach for the management of cancer cachexia.  
 
MENAC (Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia) is 
a multi-centre multimodal intervention ongoing trial since 2014. Advanced cancer 
patients undergoing chemotherapy are recruited and the effect of multimodal 
intervention will be studied with the help of parameters such as body weight, muscle 
mass and physical activity (Karra, 2014). 
 
Every treating oncologist ideally aims at reversing body weight loss and muscle 
wasting in a cachexic patient however a realistic goal of weight maintenance and 
symptom control should be the objective. (Suzuki et al., 2013). We therefore 
propose a nutrient rich natural food (IAtta) intervention along with counselling which 
has shown weight maintenance in small number of cachexia free-living patients and 
quality of life improvement (Kapoor et al., 2016) 
 
2.8 Nutritional counselling and 
supplementation in advanced cancer patients 
 
Nutritional managment is an essential part of palliative care and enhances QoL and 
patient nutritional status. Decline in nutritional intake leads to fatigue, weight loss 
and poor functional ability. The dietician has the burden to design tailored nutritional 
plan keeping in mind patients’ diesase trajectory and therapy symptoms 
(Richardson and Davidson, 2015, p. 192).   
 
Dietary counselling sessions aid the dieteician in understanding patients nutritional 
difficulties, their requirements and limitation to adhere to drafted nutritional plans. 
Building a relationship with the patient using good communication skills during 
consultation sessions results in setting realistic nutritional goals and educating 
them. Promoting patient and carer involvment during dietary planning may lead 
towards a tailored efficient care stratergy (Richardson and Davidson, 2015, p. 198).  
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Oral nutritional supplements (ONS) are intended to be added to patients respective 
daily diet (Table 2.8-1). Most commonly ONS are administered in liquid form 
providing 1.5kcal/ml and 0.6g/ml of protein per serving (200-250ml). Compliance 
with ONS intervention is often poor but has improved in the recent past (Richardson 
and Davidson, 2015, p. 194). Palliative care patients have often complained of 
changes in taste and smell. It is therefore advised to offer ONS in different flavours 
and forms to improve compliance. Daily normal food should be presented in an 
attractive fashion, small portion size with increased nutrient density and modified 
consistency (Richardson and Davidson, 2015, p. 194). Advising frequent, small, 
energy and protein dense snacks will give more food options than ONS 
prescriptions (Baldwin, 2015). 
 
One literature review has pointed out that dietary counselling in advanced cancer 
cachexic patients can impact energy intake and body weight (Balstad et al., 2014). 
A recent systematic review by Lee et al., (2016) on nutritional interventions in 
cancer patients concluded that nutritional counselling with or without ONS intake 
improved their nutritional status, reducing malnutrition levels. Nutritional counselling 
maintained body weight, BMI and PG-SGA change. Studies involving only ONS 
interventions had insignificant and low improvement in weight gain, BMI and PG-
SGA levels among malnourished ancer patients, while a meta analysis by Baldwin 
et al., (2012), which included 13 RCTs involving malnourished cancer patients, 
concluded that there was no statistically significant relationship between synthetic 
ONS intervention and body weight gain. Another review by Baldwin and Weekes 
(2012) conlcuded that malnourished cancer patients gained more weight on 
receiving dietary counselling and ONS compared to patients on usual care. 
 
Table 2.8-1: Literature review on oral nutritional supplement (ONS) intervention 
studies in advanced cancer patients during the last five years (2010- 2015) 
Author Intervention Variables Outcome 
Dewey et al., 
(2015) 
SG – Prosure (ONS 
containing EPA) 
CG – Ensure plus (ONS) 
Intervention continued for 2 
months 
Body weight, 
and QoL 
Stabilization of weight 
loss in both group (p= 
0.48) and longer 
survival in SG (three 
times longer than CG, 
p=0.09). No significanct 
diffrence in QoL 
between groups after 
intervention (p = 0.46). 
Sánchez-Lara SG: Protein rich ONS Body weight, fat CG had significanct 
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et al., (2014) containing n-3 fatty acids 
Prosure 
CG- Follow a diet based on 
1400-2200Kcal 
Intervention for 6 months 
mass, lean body 
mass, CRP, 
serum albumin, 
EORTC- 
QLQ30C 
weight loss (p<0.001) 
while body weight 
maintained (p=0.523) in 
SG patients. CRP 
decreased 
significanctly (p=0.02) 
in SG and maintained 
in CG patients. 
Significanct 
improvment in global 
health status, appetite, 
fatigue (p<0.05) while 
CG reported no 
differences after 
intervention. 
Poulsen et al., 
(2014) 
SG: Nutrition counselling. 
Protein rich ONS 
containing n-3 fatty acids 
Forticare offered to 
palliative oncology patients 
receiving 
chemoradiotherapy 
CG- Nutritional counselling 
by nurses 
Intervention up to 3 months 
Body weight, 
nutritional 
status, dietary 
intake, QoL 
No significant 
improvment between 
groups at the end of 
intervention period. 
QoL no significant 
difference between the 
groups. SG had 
significant higher 
energy and protein 
intake daily compared 
to CG patients at the 
end of intervention. 
Percival et al., 
(2013) 
SG – Nutrition counselling. 
Energy and protein rich 
ONS supplied to 
malnourished or patients at 
risk of malnutrition 
CG- Not includded 
Intervention for 1 month 
Body weight and 
survival 
Body weight was stable 
in 27%, increased in 
42% and decreased in 
31% of enrolled 
patients post 
intervention. Two third 
of patients body weight 
stabilized or increased 
after one month. No 
diffrence was observed 
in survival rate (p= 
0.16) 
Yeh et al., 
(2013) 
SG: EE- ONS enriched 
with omega-3 fatty acids, 
micronutrients and 
probiotics. 
Group 1 with 
BMI<19Kg/m2 (n=12). 
Group 3 with 
BMI>19Kg/m2 (n=18). 
CG: oral nutritional formula 
Isocal Nestle (doesn’t 
contain Omega 3 and 
probiotics) 
Body weight, 
BMI, serum 
albumin & pre 
albumin 
SG group with 
BMI<19Kg/m2 
significantly improved 
body weight and 
maintained higher 
serum albumin & pre-
albumin compared to 
CG (p<0.05). 
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Group 2 with 
BMI<19Kg/m2 (n=20). 
Group 4 with 
BMI>19Kg/m2 (n=18) 
 
Intervention for 3 months 
Ravasco et 
al., (2012) 
SG1: Nutritional 
counselling 
SG2: ONS intervention 
CG: Standard care 
Intervention continued for 5 
years 
Weight, PG-
SGA, QoL 
Nutritional status was 
maintained in group 
SG1 while SG2 and CG 
had severe detoriation 
in their nutritional status 
(p < 0.002). Intake was 
lower in SG2 and CG 
group compared to 
SG1(p = 0.001). QoL 
scores of SG1 were 
higher/better than SG2 
and CG (p<0.002). 
Weed et al., 
(2011) 
Prosure - EPA-containing 
ONS 
 
Intervention for average 
11+0.85 days. 
(n=38) 
Body weight, 
lean body mass. 
At the time of discharge 
patient showed 
significant (p<0.01) 
increase in lean body 
mass. 
Baldwin et al., 
(2011) 
G1: no intervention (n=96), 
G2: dietary advice (n=90)  
G3:nutritional supplement 
Scandi shake or Calshake 
(n=86) 
G4: dietary advice plus 
supplement (n=86) 
Intervention period 1Year 
Weight, Hand 
grip strength, 
EORTC C30 for 
QoL. 
Significant weight gain 
(p=0.002) from 
baseline to 12 weeks, 
independent of 
nutritional intervention 
and group allocated. 
 
QoL & Hand grip 
strength no significant 
difference between 
group. 
van der Meij, 
B et al., 
(2010) 
 
and 
 
van der Meij, 
B et al., 
(2012) 
SG: Prosure ONS energy 
and protein dense with 
EPA+DHA 
(n=20) 
 
CG: Ensure without EPA 
and DHA 
Intervention 5 weeks 
(n=20) 
BMI, FFM, 
MUAC, C 
Reactive 
Protein, Serum 
albumin, 
leucocytes, 
serum TNF, 
serum IL-6. 
 
EORTC and 
physical activity. 
SG had better weight 
and FFM maintenance 
than CG (p<0.05). SG 
had a greater MUAC 
than CG but not 
significant. 
C-reactive protein, 
serum albumin, serum 
TNF, serum IL-6 levels 
were not different in 
both the group during 
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Period of intervention 5 
weeks 
intervention. 
 
SG tended to have 
higher level of physical 
activity after 5 weeks 
(p=0.05) compared to 
the CG. 
Quality of life 
parameters were noted 
to be significantly 
higher (p= 0.04) in SG 
compared to CG 
Trabal et al., 
(2010) 
 
SG: Prosure ONS energy 
and protein dense with 
EPA+DHA and dietary 
counselling 
(n=5). 
 
CG: Dietary counselling 
(n=6). 
 
Period of intervention 12 
weeks 
Weight, serum 
protein, QoL by 
EORTC QLQ-
C30 
SG reported statistically 
significant (p= 0.045) 
weight gain compared 
to CG. 
No significant change 
in plasma protein and 
QoL parameters. 
 
van den Berg 
et al., (2010) 
SG – Nutrition counselling. 
Energy and protein rich 
ONS supplied if daily diet 
did not meet intake goals. 
CG - Standard care. ONS 
advised when intake was 
insufficient 
Intervention for 2 months 
Body weight, 
Malnutrition 
(assessed by % 
body weight 
loss) 
SG reported significant 
decrease in weight loss 
comapred to CG 
(P=0.03).Malnutrition 
level decreased in SG 
and increased in CG 
(P=0.02) 
 
(SG= Supplementation group, CG= Control Group, EPA= Eicosapentaenoic acid, 
DHA= Docosahexaenoic acid, SFT= Skin fold thickness, FFM= Fat free mass, 
TNF= Tumour necrosis factor, IL-6= Interleukin-6, EORTC-QLQC30= European 
Organisation for Research and Treatment of Cancer-Quality of Life, QoL= Quality of 
Life, PG-SGA: Patient Generated - Subjective Global Assessment, SGA= 
Subjective Global Assessment) 
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A number of intervention studies have shown a beneficial effect of n-3 fatty acid like 
eicosapentaenoic acid on advanced cancer cachexia patients, but according to a 
systemic review by Ries et al., (2011), there is a lack of evidence to support n-3 
fatty acid supplementation in cancer cachexia patients. EPCRC guidelines for 
cancer cachexia patients also state that, there is limited evidence to demonstrate 
the advantage of n-3 fatty acid administration in advanced cancer patients 
(Radbruch et al., 2010). 
 
Patient tailored nutrition intervention has resulted in a favourable treatment 
response among advanced cancer patients. A patient specific nutritional 
intervention (TiCaCo) under the supervision of trained dieticians and nutritional care 
experts was tested for 12 months on cachectic malignant patients. According to 
each patients’ calculated energy expenditure, calorie intake goals were finalized. 
The personalized dietary plan consisted of meals providing 30–35% fat (maximum 
10% saturated fat), 50–55% carbohydrates, 10–15% protein and minimum 30 g of 
dietary fibers daily of the total calories aimed. After the intervention period, patients 
receving dietary plan had a weight gain of 1.29 ± 3.76Kg while the control group 
patients (receiving standard hospital care) had lost 5.8Kg. Unexpected 
hospitalization among control group patients was significantly longer than patients 
from the nutrition therapy group (37.6 vs. 3.4 days) (DeWaele et al., 2015). Cong et 
al., (2015), tested a similar approach and planned a nutritional intervention along 
with dietician and nurses for advanced cancer patients receiving anti-cancer 
treatment. Nutritional goal set for the study group patients was, energy 30-
35kcal/Kg, protein 1.5g/Kg, fat 1.3g/Kg and carbohydrate 3g/Kg per day while the 
control group patients were treated by physicians (ONS was prescribed if 
requiered). Nutriitonal status of study group patients’ was better compared to control 
group patients (Pre-Albumin, transferrin and albumin significant difference between 
group, p=0.001, p<0.001, p<0.001 respectively). Study group patients’ maintained 
their body weight throughout treatment (p=0.412) while the control group patients’ 
body weight reduced (p= 0.001) (Cong et al., 2015). A diet plan was designed 
according to an east Indian dietary pattern consisting of local foods providing 
2906Kcal, carbohydrate 434g, protein 133g and 81g fat daily for 1 year or until 
chemoradiotherapy was completed by study group patients (head and neck). 
Control group patients received a similar dietary plan providing 2104kcal, 
carbohydrate 380 g, protein 77.7 and 31.6 g fat daily. At the end of intervention 
period the study group patients had gained 3.5% body weight, protein levels 
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improved by 33.33% and 45% reported good nutritional status (NAI assessment). 
SFT improved in both groups on completion of intervention (Bhattacharjee et al., 
2015). 
 
According to Prado et al., (2013), if nutritional intervention is introduced in early 
stages of cachexia it can aid in building body stores. During this observational 
study, CT images of advanced cancer patients from the start of the treatment until 
death were studied. Continuous loss of muscle and adipose tissue was observed 
and the patients were progressively catabolic closer to the time of death (catabolism 
level increased from 9 month to 1 month before death). Muscle gain was noticed in 
patients with stable disease or responding to therapy, as well as with symptom 
improvments during treatment. Increase in skeletal muscle was noticed in few 
patients within a year before death. Therefore, if nutritional support is rendered to 
advanced cancer patients during the initial phase of disease (before 90 days of 
death) anabolism will help in delaying cachexia progression (Prado et al., 2013). 
In a community setting with minimum availability of resources, nurses can identify 
and assess cancer patients suffering from malnutrition as well as provide advice on 
high energy and protein foods as part of essential dietary counselling (Gillespie and 
Raftery, 2014). 
 
2.9 Advantages of physical activity for 
advanced cancer patients 
 
In the recent past, palliative cancer patients were advised rest by recommending 
physical inactivity to reduce energy expenditure (Oechsle et al., 2011). Ambulatory 
advanced cancer patients have reported average reduction of 40-50% of their 
physical activity level (Baracos et al., 2015, p.713). Cancer- related fatigue (CRF) is 
commonly reported among advanced cancer patients. More than 80% of patients 
receiving anticancer therapy have experienced CRF (Alexander et al., 2016). 
 
The National Comprehensive Cancer Network (NCCN) defined cancer-related 
fatigue as follows: ‘Cancer-related fatigue is a distressing persistent, subjective 
sense of physical, emotional, and/or cognitive tiredness or exhaustion related to 
cancer or cancer treatment that is not proportional to recent activity and interferes 
with usual functioning’ (Berger et al., 2010) (Yennurajalingam and Bruera, 2015, p. 
Nutrition Intervention in Indian Cancer   Chapter 2 
28 
410). NCCN recommends activity enhancement as part of non-pharmacological 
management of CRF. 
 
According to Clinical Practice Guidelines on Cancer Cachexia in Advanced Cancer 
Patients by the EPCRC (2010), physical activity is strongly recommended in the 
management of cancer related cachexia. It may help to boost the immune function 
and suppress inflammatory responses (Ardies, 2002). This could also aid in slowing 
down decreased physical function and improve quality of life (Radbruch et al., 
2010). Lowe et al., (2012) reported a positive association between physical activity 
and quality of life among fifty advanced cancer patients attending an out-patient 
palliative care clinic in Canada. Palliative chemotherapy patients have also 
demonstrated better QoL, with physical activity levels of nine hours or more per 
week (Oechsle et al., 2011). A systematic review has reported physical activity 
(walking and cycling) could reduce CRF in patients undergoing treatment for cancer 
(Cramp and Daniel, 2012). Another systematic review focusing on lung cancer 
patients recommended CRF screening for all lung cancer survivors and supported 
exercise intervention for CRF management (Paramanandam et al., 2015). 
 
A study on 188 advanced palliative cancer patients who were enrolled under a 12-
week physical activity program (mainly walking) observed strong improvement in 
fatigue levels and maintenance in body weight (Gagnon et al., 2013). Group 
exercise session among palliative cancer patients involving physiotherapists, social 
workers, dieticians, nurses, social workers and physicians was introduced for eight 
weeks. After completion of the program, patients reported improvement in their 
nutritional status, symptom severity, performance status, fatigue and physical 
activity level (Chasen et al., 2013). Advanced cancer patients attending palliative 
care clinics were recruited for a two month physical activity program involving walk 
test and grip strength assessment. Following completion of program, patients 
reported significant improvement in their performance status (walk test), hand grip 
strength and body weight compared to the patients receiving standard treatment 
(Oldervoll et al., 2011).  
 
Advanced cancer patients undergoing chemotherapy were enrolled in a supervised 
multimodal exercise training program for six weeks while the control group patients 
received conventional medical care. At the end of training, participating patients had 
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significant improvement in their muscular strength, oxygen consumption, fatigue, 
physical functioning and emotional well-being (Adamsen et al., 2009).  
 
Breast and colon cancer patients undergoing chemotherapy and receiving 
supervised physical activity experienced improved fatigue levels, muscle strength, 
physical functioning as well as less vomiting and nausea (Waart H et al., 2015). 
 
Chemoradiotherapy negatively impacts the oxygen transport cycle in the body and 
therefore hampers oxygen transport. Head and neck cancer patients on anticancer 
therapy undergoing six week structured exercise training with walking improved 
their functional capacity. Exercise improves oxygen transport in the tissues, thus 
improving function of the peripheral muscles by increasing muscle oxygen uptake. 
Quality of life improved for these patients while functional capacity decreased by 
18% among control group patients who were on standard treatment plan (Samuel et 
al., 2013).  
 
Performing traditional breathing Yoga exercises (Sudarshan kriya and pranayam) 
daily for 20 minutes among advanced breast cancer survivors has shown to be 
helpful in reducing stress and pain perception (Kumar et al., 2013). 
 
Due to fatigue and loss of muscle mass the patients become isolated and 
experience frustration. Patients therefore should be counselled regarding role of 
physical activity in correcting muscle wasting. Patients should maintain their routine 
of household activities and aim for daily walking. Individualised exercise plan from a 
physiotherapist can further benefit patients (Baracos et al., 2015, p.712). Currently 
physical activity is overlooked within the palliative health care system in India. 
  
2.10 Quality of life of patients living with cancer  
 
Quality of life (QoL) covers multidimensional measures related to health, disease 
and medical therapy. In palliative medicine QoL is associated with symptom control, 
physical function, social functioning and psychological fulfilment, existential and 
spiritual domains (Kassa and Loge, 2015, p.1201). QoL is a patients’ view regarding 
their health according to their satisfaction. Different dimensions of QoL are 
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dependent on setting/surroundings they are based on, symptom severity, disease 
coping ability, spirituality, etc. Patients QoL has an impact on their daily activity 
performance, ability to pursue work and interpersonal relationships (Lis et al., 2012).  
 
To assess QoL among palliative cancer patients, disease specific instruments have 
been developed like EORTC- QLQ- C30 and Functional Assessment of Cancer – 
General Version (FACT-G). These instruments cover aspects of physical and social 
functioning as well as symptoms. According to EORTC, core QLQ-C30 
questionnaire can be supplemented with cancer site specific questionnaires. 
EORTC QLQ C30 is frequently used in Europe while FACT-G is used in the United 
States. World Health Organization Quality of Life Assessment instrument 
(WHOQOL) consists of five domains using 100 items (of physical and psychological 
health, independence levels, social functioning, spirituality and environment). 
WHOQOL is a generic instrument and therefore in palliative care cancer studies 
EORTC- QLQ and FACT- G are preferred (Kassa and Loge, 2015, p.1203). Few 
other QoL assessment tools are Functional Living Index cancer questionnaire 
(FLIC), Spitzer Quality of Life Index (QLI), Rotterdam Symptom Check List (RSCL), 
the Medical Outcome Study, 36-item short form (MOS SF-36), EuroQol (EQ-5D), 
the Cancer Rehabilitation Evaluation System (CARES) and the Symptom Distress 
Scale (Kapoor et al., 2016). 
 
Studies reveal the following: 
The functional domain and symptom scale (loss of appetite and dyspnoea) showed 
association with ONS intake in malnourished cancer patients (Baldwin et al., 2012). 
Observations of malnourished cancer patients suggests decline in quality of life with 
body weight loss (Thoresen et al., 2012; Wallengren et al., 2013). Weight loss 
greater than 10% has been significantly associated with decreased global QoL, 
increased fatigue and pain. Nutritional status is positively correlated with QoL. (Lis 
et al., 2012). 
 
2.11 Dietary pattern of Indians 
 
In India, only 30% of the population lives in urban areas while 70% resides in the 
rural part. Compared to other countries, the proportion of Indians living in the rural 
part is the highest in the world (Goss et al., 2014). 
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Dietary pattern in India is dependent upon the religious and cultural practices as 
well as family values. The majority of the people in India are vegetarians (10% - 
62% for different states). The vegetarian diet consists of variety of vegetables, roots 
and tubers, fruits, cereals and pulses served with curries using spices and 
seasoning. Vegetarian diets are low in protein, zinc and vitamin B12 content 
(Shridhar et al., 2014). Diets also depend on local food availability and agricultural 
practices (Green et al., 2016). Indians consume home cooked meals three times a 
day. Among the rural population the food take away concept is uncommon. Women 
are more likely to be vegetarian compared to men (except in northeast India) 
(Arnold et al., 2009). In India, the traditional flat bread ‘Chapatti’ is consumed daily 
approximately by 50% of urban and rural people along with curry (Bansal et al., 
2010). It is made of whole wheat flour, which is called Atta. Cereal and millets form 
the bulk in rural population diets (National Nutrition Monitoring Bureau, 2012). 
According to dietary intake Indian Migrant Study survey (Satija et al., 2015) carried 
out among factory workers, cereal based diets consisting of whole grains and rice 
served with potato and other vegetables was the most common. Snacks, milk and 
its products, nuts, chutney or pickles along with meals was also consumed. The 
other two patterns observed were, western cereals along with vegetables, fruits and 
milk products and a pattern based on animal foods. On studying dietary patterns 
among different regions of India it is seen that meat and fish consumption is popular 
in East and South part compared to North and West. Also, populations living in 
North and West part had fruit, vegetables, rice and pulses in their diets while sweets 
and snacks were common in East and South India (Green et al., 2016). A recent 
study carried out in the northern part of India among urban low-middle socio-
economic adult females also observed that more than half of their study population 
practiced vegetarianism. Their diet mainly consists of cereals, pulses, roots and 
tubers (Agarwal and Varma, 2016). 
 
There is a need to develop a natural nutritional supplement meal that can be 
prepared with minimal training at home using locally available sustainable 
ingredients. Such a meal can help correct nutritional deficits and improve treatment 
outcomes among poor cancer patients (Kapoor et al., 2016). 
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2.12 Nutritional status of Indian adults 
 
The National Nutrition Monitoring Bureau (NNMB) survey (2012) studied the diet 
and nutritional status of rural Indian population. Intake of green leafy vegetables, 
milk and milk products and sugar was 50% less than the recommended dietary 
allowance (RDA) in more than half of the households. Except thiamine, median 
intake of all other nutrients was lower than the RDA among households. Intake of 
riboflavin and Vitamin A was less than 50% of RDA by 50%-81% of the households. 
Adequate intake of protein and energy was 63% among adult males and 71% for 
non-pregnant and non-lactating adult females. Prevalence of energy deficiency (BMI 
< 18.5) was noticed in 35% of the adults. Protein intake was 47g/d and energy was 
1787 kcal among all Indian households, lower than the recommended amount of 
60g/d and 2320kcal/d respectively. Household survey concluded that the average 
consumption of pulses and legumes was about 31g/d, lower than the suggested 
level of 40g, in most of the States, while green leafy vegetables and other 
vegetables consumption was very low at 18g/d and low at 46g/d compared to 
recommended 40g/d and 60g/d respectively. Except the western state of Gujarat, all 
states reported low average consumption of milk and its products at 85ml/d 
compared to the suggested value of 150ml/d. Among micronutrients intake, calcium 
was 331mg/d, iron 12mg, Vitamin A 124microgram/d, riboflavin 0.8mg/d, Vitamin C 
29mg/d and folate 118microgram/d was lower than the recommended intake 
(National Nutrition Monitoring Bureau, 2012). 
 
Average cereals and legumes intake among non-pregnant and non-lactating adult 
female was 341g and 28g per day respectively; this is lower than the 
recommendation. These females reported reduction of 500kcal/d intake and 13g/d 
of protein intake over a four decade period. Decline in intake of cereals, milk, sugars 
and nuts was also noticed, while micronutrient intake was less than 50% of RDA 
among most of them (National Nutrition Monitoring Bureau, 2012). 
 
The survey concluded that there was inadequate intake of energy and proteins and 
the diet was also severely deficient in iron, riboflavin, folic acid and Vitamin A 
among the Indian rural population (National Nutrition Monitoring Bureau, 2012).  
 
A study of non-pregnant and non-lactating adult female residing in Rajasthan 
(northern state of India) assessed the dietary intake using dietary recalls and food 
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frequency questionnaire. They found 70% of their participants consumed less than 
1900Kcal/d along with low (30% less than recommendation) consumption of fruit, 
green leafy and other vegetables. Therefore, low (22% - 57% of RDA) dietary intake 
of iron and folic acid was observed, leading them towards anaemia. (Agarwal and 
Varma, 2016). 
 
2.13 Tailored Food Recipe (TFR) concept for 
nutrition sensitive intervention 
 
The phrase “Let food be the medicine and medicine be the food” by Hippocrates 
coined centuries back is the approach nutritionist as well as food scientists are 
following today. Nutrients in natural foods are bound to plant organelle matrix 
influencing its digestion and absorption in the gastrointestinal tract. Therefore, 
methods to deliver natural food to the body in order to maximize the healthy effect of 
exsisting bioactive compounds within the plant matrix, requires inputs from a team 
of food scientists, nutritionists, engineers, medical researchers and psychologists. 
Bioavailability can be defined as nutrients consumed which are accessible and 
available to support bodily physiological processes or stored in fat cells. 
Determination of nutrient bioavailability is important while selecting ingredients for 
development of food recipes to provide health benefit. Basic food processing like 
grinding and mild heat treatment degrade the food matrix, improving nutrient 
availability (Sensoy, 2014). 
 
Scientific combination of selected, commonly consumed food ingredients can 
improve the nutritive value of formulated product known as tailored food recipes 
(TFR) (Amlogu et al., 2011, 2012, 2013, 2014 a and b, 2016). A TFR can be defined 
as “a blend of locally available, affordable, culturally acceptable and commonly 
consumed foodstuffs mixed proportionately, drawing on the ‘nutrient strengths’ of 
each component of the mix in order to optimise the nutritive value of the end-
product without the need for fortification” (Amuna et al., 2004). Nutrients in food 
naturaly interact with each other and may improve their absorption and impact 
bodily functions (Zotor et al., 2006, 2015). 
 
Nutrition sensitive intervention works on similar concepts. Designing a nutrition-
specific optimum mix of foods to target malnutrition among poor populations can 
address food security. Nutrition sensitive intervention meals have the potential to 
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address global malnutrition as well as support the development of enterprises (small 
and medium-sized) (Ruel et al., 2013). 
 
The TFR and nutritional sensitive intervention concept aims to improve nutritional 
status in resource-poor environments with limited local food ingredients and to 
develop a recipe for multiple uses such as health maintenance and therapeutics 
(Zotor et al., 2015). 
 
Amtewa meal (TFR) has shown delay in progression of human immunodeficiency 
virus (HIV) to acquired immune deficiency syndrome (AIDS) in Nigerian palliative 
patients. Patients consuming the meal daily for six months had better nutritional 
status and improved immunological response at the end of the intervention (Amlogu 
et al., 2014). Therefore, it is an established fact that TFR (based on Amtewa meal 
composition) has a positive impact on health status of undernourished immune 
suppressed palliative patients (Amlogu et al., 2011, 2012, 2013, 2014 a and b, 
2016). 
 
2.14 Palliative care for Indian cancer patients 
 
The World Health Organisation (WHO) defines palliative care as “an approach that 
improves the quality of life of patients and their families facing the problem 
associated with life-threatening illness, through the prevention and relief of suffering 
by means of early identification and impeccable assessment and treatment of pain 
and other problems, physical, psychosocial and spiritual” (WHO, 2007). It has been 
estimated that 80% of advanced cancer patients need symptom management and 
therefore palliative care plays an essential role in providing patients’ symptomatic 
relief (Ministry of Health and Family Welfare, 2012). Nine hundred and eight 
palliative care centres exist in India but 841 of them are based in Kerala (southern 
state of India). Kerala has incorporated palliative care policies and receives 
government funding to hold community based care programs. NGO’s in Kerala 
involve volunteers to provide home based care to palliative patients. After training, 
volunteers provide psychological, social and spiritual support to patients and their 
families. However, in the rest of India, majority of the population cannot access 
quality palliative care treatment, only 1% of suffering patients receive it (Ministry of 
Health and Family Welfare, 2012). 
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Studies have concluded that early introduction of palliative care along with anti-
cancer treatment extends survival rate compared to patients receiving only anti-
cancer therapy (Ministry of Health and Family Welfare, 2012).    
 
Palliative care should be introduced into the cancer patients care plan early in the 
disease trajectory. For effective patient managment, palliative care should be 
initiated during diagnosis and continued during treatment and covers bereavement 
help to the family after patients’ death (Ministry of Health and Family Welfare, 2012) 
(Figure 2.13-1). 
 
 
Figure 2.13-1: Cancer patient care model including curative and palliative treatment 
(adapted from Ferris et al., 2009) 
 
The Indian Association of Palliative Care was formed in 1994 in collaboration with 
WHO and the government of India. Their main aim is to provide care for patients 
suffering from life threatening end stage chronic diseases using a multidisciplinary 
approach and educating health care providers. Few non-profit government 
organization (NGO) run by volunteers, charities, fundraisers and patient payments 
are also involved in providing quality care to needy patients (Ministry of Health and 
Family Welfare, 2012). One such is Pallium India, established in 2003 providing 
palliative care in 11 states of India funded by National Rural Health Mission. They 
serve the rural population through community health centres’ (Rajagopala, 2015). 
NGO’s established in palliative care have considerable experience and could be 
used by government to spread awareness in the community (Ministry of Health and 
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Family Welfare, 2012). The Indian palliative care system involves occasional patient 
home visits, regular outpatient clinics and an established in-patient facility for severe 
symptom management. This cost-effective management was developed by Pain 
and Palliative Care Society (PPCS) and helps in reaching majority of the patients 
with the limited resources allotted by the Health Ministry (Rajagopala and George, 
2015, p.14).   
 
India lacks established guidelines for palliative care services, trained health 
professionals, training infrastructure, awareness and centres to provide quality 
treatment for end of life patients (Ministry of Health and Family Welfare, 2012). 
However, the palliative care manual by Ministry of Health and Family Welfare (2005) 
does mention general nutrition guidelines (merely six guidelines). There is lack of 
directions and specificity as regards to quality and quantity of macro and 
micronutrients to be provided for maintenance of palliative cancer patients’ health 
status.  
 
Palliative care should ideally work towards cancer prevention, early diagnosis and 
treatment for the suffering population. In a traditional society like India, family 
members are involved in caring for patients. Palliative care services should develop 
simple care guidelines to empower family members and caregivers for optimum 
patient management in the household setting. Developed care guidelines should be 
according to Indian cultural beliefs, involving family members and using sustainable 
resources (Rajagopala and George, 2015, p.13). 
 
2.15 Justification of proposed study 
 
The central and state governments spend less than 1.5% of its gross domestic 
product (GDP) on public health care. Development of better infrastructure and 
management in cancer care would be difficult if the central and state governments 
do not increase public health allocated budget and allowances. Increased 
expenditures on public health care should be India’s national policy priority (Mallath 
et al., 2014). 
 
In spite of established guidelines for diagnosis of cachexia (by EPCRC) in cancer 
patients, these guidelines are not adopted by majority of the Indian public hospitals 
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and therefore the medical management of all cancer patients is not optimal. This is 
the impression one gets after visiting the various hospitals.  
 
Despite, the endorsement of nutritional guidelines for cancer and undernourished 
patients by many international organisations, such as: ESPEN (Arends et al., 2016; 
Arends et al., 2006; Bozzetti et al., 2009); NICE (National Collaborating Centre for 
Acute Care, 2006); ASPEN clinical guidelines in adult anticancer treatment (August 
et al., 2009); EPCRC (Radbruch et al., 2010); Australian guidelines for nutrition 
management of cancer cachexia in Adults (Bauer et al., 2005) and SFNEP non-
surgical anticancer treatment guidelines (Senesse et al., 2014), the nutritional 
guidelines for Indian cancer cachexia patients are currently absent with no specific 
recommendations for free living cachexia patients. There is no such documentation 
available, hence this is being stated. 
 
It has been documented that nutritional intake of cancer patients is calorie deficient 
and they suffer from micronutrient deficiencies (Balasubramaniyan et al., 1994; 
Singh et al., 2005; Goyal, et al., 2006; Naidu et al., 2007). In the absence of energy 
dense nutrient rich supplements in their diets, the nutritional requirement of these 
patients are not met and this puts them in jeopardy (Thoresen et al., 2002). In spite 
of these known facts nutrition is ignored in the palliative care framework of Indian 
cancer patients. 
 
Interventions with synthetic oral nutritional supplement (ONS) drinks (based on 
energy and protein dense supplemented with omega-3) among advanced cancer 
patients have shown body-weight gain, increased lean body mass and better quality 
of life (See table 2.8-1). However, scientific appraisal is required with respect to their 
bioavailability, sustainability, food security and suitability for vegetarians.  
 
2.16 Originality of the research 
 
Development of ‘Improved Atta’ of this current study is multidimensional. IAtta 
addresses the following issues:  
 
Vegetarianism: The majority of Indian population is vegetarian, therefore it was 
important to include only vegetarian ingredients (for instance, the IAtta supplement 
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consisted of roasted horse gram, roasted barley flour, roasted soybean flour, 
amaranth spinosus and flax seeds in dry powder form). Most of the commercial 
ONS contain fish oils which is not acceptable among most of the Indian population 
therefore a vegetarian option for omega 3 fatty acids like flaxseeds (in IAtta), if 
added in diets of undernourished cancer patients is likely to improve their nutritional 
status. 
 
Bioavailability: IAtta is made up of 100% natural local ingredients and therefore 
bioavailability will be higher than the commercial ONS (Buchman, 2006; Ball, 2006; 
Rude and Shils, 2006; King and Cousins, 2006; Wood and Ronnerberg, 2006).  
 
Sustainability: All ingredients used in IAtta are locally produced and very easily 
available at most grocery stores in the urban as well as the rural areas. Commercial 
ONS are mostly available at urban pharmacy outlets, making it inaccessible for the 
rural patients. 
  
Food security (local produce and readily available and low costs): Grains like 
barley and soybean, pulses like bengal gram, oilseed like flaxseed and amaranth 
green leafy vegetable are grown in most parts of India. As these products are 
produced in the country, it is quite affordable and available round the year in most 
grocery stores. Thus IAtta accessibility for patients from rural as well as urban 
background is feasible.  
  
Cancer patients who are at nutritional risk have shown better quality of life when 
their diets are supplemented with ONS (Baldwin et al., 2012). It has been suggested 
that advanced cancer patients receiving nutritional supplementation (along with 
exercise counselling) may improve physical strength (Payne et al., 2013). In the 
Indian palliative care system, nutritional status of cancer patients is not usually 
assessed. Only hospitalised cancer patients have dietetic consultations. Doctors’ 
advise patients, in a generic fashion, during consultation merely to eat healthy food 
and frequent meals. If nutrition (i.e. counselling and intervention program) is added 
to the multi-dimensional approach to treat palliative cancer patients in India, they 
are likely to experience better QoL and be less dependent on the caregivers.
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3.1 Introduction 
 
In this prospective randomized controlled nutrition intervention we recruited female 
free-living cancer cachexic patients who were attending the palliative care clinic for 
symptom management. Patients with weight loss of more than 5% from pre- 
treatment weight or BMI less than 20 Kg/m2 along with haemoglobin level less than 
12g/dl and energy intake of less than 1500kcal/d were considered eligible for 
participation. Patients with gastrointestinal tract disorders, on anabolic steroids, 
taking synthetic oral nutritional supplements and with life expectancy of less than 
three months were excluded from participation. We developed a TFR acceptable by 
the Indian community and easy to prepare according to taste preferences for 
correction of patients’ nutritional status. The intervention was carried out at Dr. BRA 
Institute Rotary Centre Hospital (Dr BRAIRCH), All India Institute of Medical 
Sciences (AIIMS), New Delhi, India. The pilot study was carried out between 
December 2013 and August 2014 and scale-up study between April 2015 and May 
2016. Out-patient department (OPD) palliative cancer patients visit Palliative Care 
experts every fortnight for treatment. During the consultation session the treating 
Palliative Care Anaesthetist counsels every patient personally to eat small healthy 
frequent meals and consume pain medication as directed. Patients’ nutritional 
status assessment and Nutritionist/ Dietician counselling session is absent. 
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Project 
documentation  
• Drafting project 
proposal 
• Designing TFR 
(IAtta) & sensory 
evaluation 
• Study 
parameters &  
questionnaires 
Desiging pilot 
study   
• Visit hospital in 
India 
• Apply for Ethics 
Approval at 
hospital & Indian 
Health ministry. 
• Meeting food 
suppliers. 
Training & 
patient 
identification 
• Organizing 
training sessions 
for hospital 
support staff. 
• Identify potiental 
study patients 
from hospital 
OPD. 
• Arranging 
counselling 
sessions with 
patients & care-
givers. 
• Piloting the 
questionnaire 
steps. 
Pilot 
 intervention 
patient pre-
assessment 
•  Collect completed 
nutritional & QoL 
questionnaires. 
• Screening for 
Anthropometric 
measurements. 
• Collating 
biochemical indictor 
data from hospital 
records 
Intervention of 
Improved Atta &  
Mid intervention 
assessment 
• Distributing 
Improved Atta 
among the 
intervention group 
of  patients for 6 
months and follow-
up. 
• After 3 months, 
anthropometric, 
nutritional &  QoL 
reassessed 
Post  intervention 
assessment 
• Assessing 
nutritional & 
anthropometric  
status of patients. 
• Quality of life 
assessment. 
• Biochemical 
indicator 
assessment. 
Evaluation of 
pilot outcome 
• Data entry and 
interpretation. 
• Report write-up 
• Adjustments to 
study design for 
scale-up 
intervention. 
Scale up 
intervention 
patient 
recruitment & 
pre-assessment 
• Identify potential 
patients for 
intervention. 
• Collect 
completed 
nutritional 
questionnaires & 
collate 
biochemical 
data, screen for 
anthropometric 
assessment. 
• Arrange patient 
counselling 
sessions.  
Intervention  
of Improved 
Atta or Placebo 
& Mid 
intervention 
assessment  
• Distribution of 
Improved Atta or 
placebo among 
patients for 6 
months and 
follow up  
• After 3 months, 
anthropometric, 
nutritional &  QoL 
reassessed 
Post 
intervention 
assessment 
• Assessment of  
patient nutritional 
status, 
antropometric 
measurements & 
quality of life. 
• Collecting 
biochecimal 
indicator result 
Evaluation 
• Data collation and 
statistical analysis  
• Data interpretaion and 
report write-up 
• Project cost-
effectiveness 
• Development of 
nutritional 
recommendations  & 
sustainibility plan 
Post Project  
Action  
• Promoting physical 
activity and healthy 
eating among cancer 
patients. 
• Educating hospital 
support staff for future 
counselling. 
• Work with Non-profit 
Government 
Organizations 
concerned with cancer 
patients to  encourage 
implementation  of 
intervention. 
3.2 Conceptual framework 
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3.3 Description of study setting 
 
All-India Institute of Medical Science (AIIMS) was created in 1956 in New Delhi, 
India. The institute provides comprehensive facilities for teaching, research and 
tertiary patient-care. It caters to millions of underprivileged Indians who are unable 
to afford quality healthcare treatment. The study was undertaken at Dr. B.R.A. 
Institute Rotary Cancer Hospital (IRCH), AIIMS and it is one of the main hospitals 
providing palliative care to cancer patients in central India. Advanced cancer 
patients attend Pain and Palliative Care OPD at IRCH, AIIMS every fortnight for 
regular consultation with the doctor and collect pain medication. During the 
consultation session the treating Palliative Care Anaesthetist counsels every patient 
personally to eat according to their food preferences and consume pain medication 
as directed. Dietician consultation is available only for patients admitted for surgery 
in the Palliative Care ward. 
 
3.4 Description of Target Population 
 
Females are considered as the inferior sex in the Indian society. Low literacy levels, 
higher death rate as compared to men and lower sex ratio are the evidence of their 
lower status in society. The Indian National Nutrition Monitoring Bureau 2012 survey 
revealed low dietary intake (i.e. 1709kcal/day) among rural and tribal (non-pregnant 
and non-lactating) women, reflecting poor nutritional status. Energy deficiency 
among tribal and rural females was 56% and 36% respectively (Roa et al., 2010; 
Arnold et al., 2009). Half of urban Indian females have been reported to be suffering 
from anaemia and chronic energy deficiency (Athreya et al., 2010). Also, due to 
existing traditional and cultural norms in the Indian society their health status is 
becoming worse, with limited access to healthcare (Roa et al., 2010). The study 
was therefore designed to reach out and help adult cancer females of low socio 
economic status. 
3.4.1 Sample size calculation for pilot study 
 
The sample size for the pilot study was calculated using nMaster software (2.0 
version), considering similar baseline weight in the two groups. After six months of 
intervention we expected a difference of approximately 10Kg of weight between the 
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intervention group and control group (i.e. at baseline mean + SD body weights of 
both the groups will be 60 + 15, while at the end of study, intervention group would 
be 65 + 15 and control group at 55 + 15). The study sample size was calculated as 
72 with 36 patients per group, in order to study the impact of intervention. This 
sample size is chosen based on confidence interval (power) of 80% for allowable 
sample error (precision limit) of 5%, however due to low recruitment rate, the study 
commenced with total 63 patients. 
3.4.2 Sample size calculation for scale- up study 
 
Sample size for the scale up was calculated using nMaster software (2.0 version) to 
compare the difference in change in mean body weight between the two groups i.e. 
intervention and control group. Based on the initial observation (pilot project) on 
limited number of patients, mean + SD change in body weight during the six months 
was observed as -0.5+1.5. To detect an improvement of minimum of 1Kg mean 
body weight as compared to the control group (i.e. mean + SD in the intervention 
group as 0.5+2.0) with 95% confidence interval and 80% power we require 50 
evaluable subjects in each of the two groups. Considering substantial drop-outs due 
to mortality and lost in follow-up, we enrolled 75 female cancer cachexia patients in 
each of the group. Thus, we enrolled 150 female advanced cancer patients in total 
for the study. 
3.4.3 Recruitment of patient 
 
Patients were recruited for pilot and scale up stage of study according to the 
inclusion and exclusion criteria. Prospective patients were screened and apprised 
about the study using patient information sheet (Appendix 1). Eligible patients were 
asked for consent (Appendix 2) and randomized equally into control and 
intervention group.  
 
Inclusion criteria 
 Female, age 18 years and above. 
 Diagnosed with advanced cancer. 
 Weight loss >5% from pre-treatment weight or BMI<20Kg/m2. 
 Haemoglobin level <12g/dl. 
 Energy intake < 1500kcal/d (to be assessed on consultation). 
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Exclusion criteria  
 Incapable to provide written consent. 
 Patient diagnosed with refractory cachexia. 
 Life expectancy < 3 months. 
 Unresponsive to anti-cancer therapy. 
 Patient is a pregnant woman or a nursing mother. 
 Patient consuming commercial ONS. 
 Suffering from secondary illnesses. 
 Gastrointestinal tract (GIT) disease which affect nutrient absorption. 
 
All cancer patients receiving chemoradiotherapy, able to consume food orally and 
digest were likely to be part of the study, subject to the above criteria. 
 
However, the novelty of this project is that every patient on the project received 
tailored nutrition information from the nutritionist depending on their symptoms and 
dietary preferences. 
  
3.5 Intervention process 
 
Patients were allocated study codes and a randomisation sheet was generated by 
using nQuery software (7.0 version) for pilot and scale-up project phase.  
 
Pilot Study: 123 female patients attending Palliative Care OPD were screened for 
eligibility and of them 63 were randomized equally into two groups i.e. control and 
intervention group. 30 patients were allocated in intervention group and received 
IAtta (100g) along with nutritional counselling and 33 patients were allocated in the 
control group who received only nutritional counselling (Appendix 3, Kapoor et al., 
2014). Patients in the intervention group collected 14 packets of 100g of IAtta every 
fortnight during their OPD appointments while the control patients were advised 
regarding their dietary habits at every OPD visit for 6 months. The study was carried 
out between December 2013 and August 2014. 
 
Scale-up Study: 329 female patients attending Palliative Care OPD were 
screened for eligibility and of them 150 were randomized equally into two groups i.e. 
control and intervention group. 75 patients were allocated in intervention group and 
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received IAtta (100g) while 75 patients were allocated in the control group and 
received whole wheat flour (100g, nutritive value table, Appendix 4) for daily 
consumption (Appendix 5). Patients collected 14 packets of 100g of IAtta/flour every 
fortnight during their OPD appointments at every visit for 6 months. The study was 
carried out between April 2015 and May 2016. 
 
Key aspects of the nutritional counselling sessions 
 
Patients were strictly advised to discard any of the dispensed leftover at the end of 
the day. Adherence to IAtta and flour (during scale-up phase) consumption was 
measured by patient (and/or caregiver) self–reporting. During follow–up counselling 
sessions, they were first queried about the number of packets left and accordingly 
given fresh packs to consume. Patients were advised to eat frequent homemade 
food. Dietary counselling for 30 minutes was imparted to all patients on each OPD 
visits by the researcher. Consumption of cereals, roots and tubers, vegetables, 
legumes, nuts, energy dense fruits, milk products (and eggs for non-vegetarians) 
was encouraged during these sessions. Weekly phone calls were made to each 
patient to enquire about their welfare and a manual record of the number of packets 
dispensed on each visit was recorded. 
 
Depending on the physical status of the patients, low level of physical activity 
(walking and/or stairs) and participation in daily household chores was encouraged 
during counselling sessions.  
 
Nutritional, quality of life and anthropometric estimation were assessed at baseline, 
after 3 months and at 6 months of intervention for all patients.  
 
3.6 Research variables and key indicators 
 
3.6.1 Quantitative variables 
 
Anthropometric parameters: All anthropometric measurements were taken by 
the same trained investigator throughout the study. The investigator took extra care 
of the patient, considering their vulnerability while taking measurements. Body 
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weight and total body water was assessed using Tanita segmental composition 
scale (BC 545N, dual-frequency 50 kHz and 6.25 kHz). Height was measured using 
a non-stretchable measuring tape. Body Mass Index (BMI: Kg/m2) was calculated 
using weight and height measurements. Mid upper arm circumference (MUAC) was 
measured using a non-stretchable measuring tape. Four site skin fold thickness 
(SFT) measurement (i.e. triceps, biceps, subscapular and suprailiac) by the help of 
scientific Harpenden Skinfold Caliper (0120 by Baty International) was noted to the 
nearest 0.2mm reading, to calculate percentage body density. Body fat percentage 
was calculated using body density value in Siri equation (Durnin and Womersley, 
1974). Questionnaire used during study is attached as Appendix 6. 
 
Nutritional status parameters: Dietary history was taken by one-to-one 
interview with the patient by the researcher. Portion size was recorded by showing 
sample vessels of different sizes (Appendix 7). The FFQ questionnaire consists of 
184 commonly consumed food items and was validated among the rural and urban 
Indian population (Satija et al., 2012) (Appendix 8). Data collected using FFQ was 
used to calculate the daily macronutrient intake of the patient. Two day 24-hour 
dietary recall (Appendix 9) data were analysed using DietCal software. DietCal- A 
Tool for Dietary Assessment and Planning software is based on book “Nutritive 
Value of Indian Foods” (Gopalan et al., 2012). Patients’ daily energy, carbohydrate, 
protein and fat intake were calculated using FFQ and recall data. PG-SGA 
questionnaire (Appendix 10) has been recommended as the nutrition assessment 
tool for cancer patients by the Oncology Nutrition Dietetic practice group of the 
American Dietetic Association (McCallum, 2006). SGA questionnaire has been 
validated among Indian cancer patients to assess level of malnutrition (Shirodkar et 
al., 2005). The PG-SGA score helped to monitor the deterioration or improvement of 
patient nutritional status throughout the study. 
  
Physical activity level: Indian Migrant Study Physical Activity questionnaire 
(IMS-PAQ) was used to assess patients’ physical activity throughout the day 
(Sullivan et al., 2012) (Appendix 11). Patients’ reported every activity performed 
with the average amount of time spent for each activity in the questionnaire filled in 
person. Metabolic Equivalent of Task (MET) was assigned to each activity 
performed according to Compendium of Physical activity (Ainsworth et al., 2011). 
The MET in simple terms is energy cost of physical activities as a multiple of the 
resting metabolic rate. One MET is equivalent to resting metabolic rate of 
1Kcal/Kg/hr (Ainsworth et al., 2011), thereby we calculated the average kilocalories 
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spent by every patient in the whole day. Hence, we were able to estimate patients’ 
total daily energy expenditure.  
 
Biochemical parameters: Cancer patients undergo routine blood tests regularly 
at the AIIMS. Blood sample collection and laboratory assessment is performed by 
trained phlebotomist and laboratory technicians following strict aseptic procedures 
at AIIMS. Haemoglobin, serum albumin and serum CRP levels were planned to be 
assessed at the start and end of the study. During the pilot study phase, serum 
CRP analysis was not a routine test in the hospital and therefore patients were 
reluctant to have blood drawn for it. Therefore, haemoglobin and serum albumin 
levels were only available from hospital records for reference during pilot project 
phase. A few patients got their CRP levels assessed from different departmental 
laboratories within AIIMS at the start and end of the scale-up intervention phase on 
investigators request. 
 
3.6.2 Qualitative variables 
 
Quality of Life (QoL) assessment: EORTC-QLQ- C30 questionnaire was used 
to analyse patients’ QoL after personal interview by the researcher (Fayers et. al., 
2001) (Appendix 12). Translated version in Hindi was available from the official 
website. The questionnaire has been validated on Indian population (Bansal et al., 
2004; Chaukar et al., 2005; Parmar et al., 2005; Mohan et al., 2007; Madhusudhan 
et al., 2009).The questionnaire consisted of 30 questions which were divided into 
five functional scales: physical, role, cognitive, emotional, and social; eight symptom 
scales: fatigue, nausea and vomiting, pain, dyspnoea, sleep disturbance, loss of 
appetite, constipation, diarrhoea, global health status and financial status. A score 
was calculated for all the 15 domains. 
 
3.6.3 Quality control of research variables 
 
All consented patients were randomized according to their study codes into 
intervention and control group to remove bias. Patient randomization sheet 
maintenance and IAtta/flour distribution was done from PhD room by Rakesh Garg 
(RG) throughout the study and the nutritionist was therefore blinded. Patient 
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counselling was done in OPD by nutritionist without the knowledge of the group the 
patient belonged to.  
 
After literature review, research variables were meticulously selected to study the 
multi-dimensional effect of IAtta on patient health status. Tanita segmental 
composition scale and Harpenden Skinfold Caliper were calibrated to zero before 
every measurement was performed. In order to minimize investigator error, all 
physical measurements were repeated thrice and were taken by the same 
investigator for anthropometric parameters. Though most of the questionnaires 
were self-reporting in nature but due to variation in education status and linguistic 
difficulties among study patient group, they were administered in the form of 
interviews by the nutritionist at all three time-points (baseline, mid–intervention and 
post-intervention). Hydration level of each patient was maintained using 
standardised procedure for optimum use of BIA throughout intervention process.    
 
The above mentioned steps were taken to maintain accuracy in data collection and 
reporting throughout the study. 
 
3.7 Statistical analyses 
 
All statistical analyses were performed using SPSS software (version 20.0) under 
guidance of trained Biostatistician’s at AIIMS.  
 
Data was expressed as mean ± sd and median (min-max) for normal and skewed 
data respectively. Quantitative normal data were analysed by using Repeated 
Measures Anova followed by Bonferroni correction. Quantitative skewed and 
qualitative data was analyzed by using Friedman test followed by Wilcoxon signed 
rank test for multi–comparisons to determine the changes within the groups at 
different time points (i.e. baseline, mid-intervention and post-intervention). Student t-
test/ Wilcoxon Ranksum tests were performed on the variables to assess the 
difference between the intervention and control group at baseline. P- value < 0.05 
was considered statistically significant.  
 
For the pilot study baseline parameters body weight, body fat, MUAC, energy 
intake, physical activity level, global health quality of life and fatigue domain were 
Nutrition Intervention in Indian Cancer   Chapter 3 
49 
adjusted to study the overall difference between groups by using generalized 
estimated equation (GEE). P-value ≤ 0.05 was considered statistically significant. 
Intention-to-treat (ITT) analysis was done in the scale-up study for the drop out 
patients. 
 
Primary endpoints for both the studies were to improve patients’ anthropometric 
status and quality of life. Secondary endpoints were maintaining physical activity, 
nutritional status and biochemical parameters.  
 
3.8 Project monitoring and evaluation 
 
Project was closely monitored at all stages from planning to evaluation phase. 
Ethics committee at UoW and AIIMS were consulted in study planning to ensure 
patient safety, addressing their requirements and considering their vulnerability due 
to the co-morbidities. Senior faculty at Pain and Palliative Care Clinic, IRCH, AIIMS 
were closely monitoring study implementation according to the proposed study 
design. They often held unscheduled patient interviews at OPD to ensure 
intervention compliance and IAtta/placebo flour acceptance. Patient data collection 
and storage was also reviewed by them. 
 
Evaluation was divided into four stages: Formative, Process, Impact and Outcome. 
 
Formative evaluation stage – Literature review during project planning phase 
highlighted that nutritional status of Indian palliative cancer patients is neither 
monitored nor addressed. Women, being considered the weaker sex in the Indian 
society (especially rural and tribal areas), were unable to access quality healthcare 
services. Once diagnosed with advanced cancer and understanding about limited 
survival time, their nutritional needs are further neglected.  
 
Synthetic nutritional supplements are available in the Indian market but are 
unaffordable by the low socio-economic strata of the society. Therefore, a need for 
affordable, vegetarian (vegetarianism is practiced by most of the Indians); energy-
protein dense food supplement was observed. AIIMS, providing good quality 
healthcare to the underprivileged people in central India was the preferred study 
setting. 
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Process evaluation stage – Patients attended the Palliative care clinic every 
fortnight for pain medications and were contacted by the project researcher during 
these sessions. A diary was maintained regarding their appointment dates and 
future treatment time plans. It was noticed initially that follow–up rate was falling and 
leading to dropouts. Thereafter, it was decided to collect two (mobile) contact 
numbers to remain in constant communication and their schedule for 
chemoradiotherapy was noted. Once a patient missed their Palliative clinic OPD 
appointment they were contacted and a counselling session was planned during 
chemoradiotherapy appointment at the hospital. If during the counselling session 
the patient mentioned they will be delaying their next appointment (i.e. next 
appointment after more than 2 weeks), they were offered to carry extra IAtta/ flour 
packets accordingly. 
Impact evaluation stage – In the recruitment phase patient diet history and 
anthropometric measurements were documented. During each follow–up visit and 
telephonic communication a 24 hour dietary recall was undertaken by the 
researcher to understand their dietary intake. Also their body weight along with 
MUAC was measured and compared with the baseline (or last follow-up reading). 
Depending on these results further nutritional counselling session was carried out. 
All baseline parameters were assessed for both groups of patients after three 
months of intervention (mid-intervention period).      
Outcome evaluation stage – At the end of intervention period (6 months of 
intervention), all baseline parameters were assessed to evaluate impact of IAtta 
supplementation, flour supplementation and nutritional counselling on intervention 
group of patients, while the effect of nutritional and physical activity counselling on 
control group patients was observed during study period. All patients were educated 
about inclusion of affordable nutritious food ingredients in their daily lifestyle and 
simple recipes to prepare them. 
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3.9 IAtta formulation and description 
 
 
Figure 3.9-1. Stepwise description of IAtta product development  
 
3.9.1 Indian dietary pattern and food secure commodities   
 
Cereals and pulses consumed in flour form by the Indian population were 
nutritionally evaluated using the textbook “Nutritive Value of Indian Foods” (Gopalan 
et al., 2012). Among various cereals and pulses listed in the book, wheat flour, 
barley flour, maize flour and chick pea flour is consumed by the Indian rural 
population either in the form of breads or porridge. Barley was chosen as the cereal 
for the formulation because of the high beta glucan levels (3-8 g/100g) and 
improved immune function efficiency (Arena et al., 2014). Soybean is high in protein 
(43.2g/100g) and regarded as local food secure pulse (Gopalan et al., 2012; 
Deshpande and Jha, 2014). According to the National Nutrition Bureau (2012), 
average Indian diets are low in protein hence soybean and chick pea were 
considered as potential ingredients for IAtta. Linseeds is the only vegetarian omega-
3 source commonly available in Indian markets as well as consumed during winters 
in savoury items (with jagerry mixed as a sweet) (Joshi, 2009,p62). Among green 
leafy vegetables; spinach, fenugreek leaves, mustard leaves and amaranth leaves 
Step 
1 
•Identification of food ingredients 
•Low cost and easily accessible local ingredients were selected               
Step 
2 
•Analysing ingredients nutritive value 
•Nutritive value was assessed using using textbook “Nutritive Value of 
Indian Foods” 
Step 
3 
•Proportionate mixing of selected ingredients 
•Selected ingredients were mixed in proportions and three formulations 
were prepared 
Step 
4 
•Sensory evaluation of three formulations 
•Three formulation were presented in porridge form by adding water for 
sensory evaluation  
Step 
5 
•Packaging and labelling 
•Seleted formulation flour mix label was designed and suitable packaging 
material was used  
Step 
6 
•Formulation distribution 
•100g of IAtta pack was distributed among patients to be consumed as 
porridge or bread form   
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are generally prepared in curry form and consumed with bread or rice as a meal 
(Hariprasad et al., 2013). On nutritive value comparison between these leafy 
vegetables, amaranth leaves had higher amount of iron and Vitamin A and therefore 
were chosen as an ingredient for the formulation (table 3.1). Green leafy vegetables 
are consumed by all groups of the society and therefore affordable (Sindhu et al., 
2016). 
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Table 3.9-1: Literature review summary of potential food ingredients locally available in Indian food market place. 
Potential 
IAtta 
Ingredients 
Roasted 
gram flour 
(Cicer 
arietinum) 
 
Maize flour 
(Zea mays L.) 
Roasted 
barley 
flour 
(Hordeum 
sativum) 
 
 
Roasted Soy 
flour 
(Glycine max) 
Amaranth 
leaves 
(Amaranthus 
spinosus) 
Spinach 
leaves 
(Spinacia 
oleracea) 
Fenugreek 
leaves 
(T. foenum-
graecum) 
Flax seeds (Linum 
usitassimum) 
Rationale 
for 
inclusion & 
advantages 
Affordable 
source of 
protein, 
folate, beta 
carotene 
and healthy 
fatty acids. 
(Jukanti et 
al., 2012) 
Low protein 
quality, vitamins 
and minerals. 
Good source of 
carbohydrate 
and 
polyunsaturated 
fatty acids. High 
in dietary fibre. 
Affordable 
cereal compared 
to wheat and 
rice (Shobha et 
al., 2014) 
Beta glucan 
in barley 
has shown 
immunomo
dulatory 
activity and 
enhances 
probiotic 
activity 
(Arena et 
al., 2014). 
Enhances the 
immune 
system. Soy 
isoflavons have 
antioxidant, 
estrogenic, anti-
osteoporotic 
effect. Consists 
of total isoflavon 
1021.5-1084.3 
µg/g (Kumar et 
al., 2010). 
Reported for 
anti-
inflammatory, 
anti-bacterial, 
immunomodulat
ory, antioxidant 
activity, anti-
pyretic, laxative, 
high 
concentration of 
essential amino 
acid (Tanmoy et 
al., 2014; 
Kumar et al., 
2010). 
Good source 
of iron and 
calcium. 
High in 
dietary fibre. 
Contains 
phytochemic
als reported 
for anti-
microbial 
and anti-
inflammatory 
activity. 
(Chaturvedi 
et al., 2013) 
Source of iron, 
silicon, and 
thiamine. Has 
hypoglycemic, 
and 
hypocholestero
laemic, effects, 
anti-
inflammatory 
effects (Moradi 
and Moradi, 
2013. 
Rich source of alpha 
linolenic acid, soluble and 
insoluble fibers, 
phytoestrogenic lignans and 
antioxidants. Reported for 
anti-inflammatory, 
antifungal, anti-thrombic 
function (Goyal et al., 2014). 
Consists of 23g of alpha 
linolenic acid (per 100g) and 
biological effect equivalent 
to 0.4g of long chain omega 
3 fatty acids (Morris, 2008; 
Rodriguez-Leyva, 2010). 
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3.9.2 Nutritive value of selected ingredient undergoing TFR 
 
The nutritive value of each ingredient was calculated using textbook “Nutritive Value 
of Indian Foods” (Gopalan et al., 2012). The textbook contains detailed nutritional 
information of more than 600 Indian food items is and recommended by the Indian 
council of medical research (ICMR). The dietary fibre content was calculated using 
usda.gov database as they were unavailable in the textbook.  
 
Each 100 g pack of TFR contained a mixture of roasted horse gram flour, roasted 
barley flour, roasted soybean flour, roasted flaxseed powder and dried amaranth 
spinosus powder (figure 3.9-1).  
 
Figure 3.9-1: Tailored Food Recipe (TFR) ingredients 
 
TFR proposed for intervention was named Improved Atta (IAtta). Atta is whole 
wheat flour in Hindi language. Indians make unleavened bread, sweet porridge as 
well as savouries using whole wheat flour. Therefore, we named our TFR, Improved 
Atta to gain patient acceptance and adapt into their dietary pattern. According to the 
patient preference the flour can be cooked and consumed by them, helping them in 
nutritional status correction. IAtta (100g/day) will help to meet the macronutrient 
demands as well as satisfy 30% - 50% of iron, calcium, and vitamin A RDA for adult 
Indian sedentary female (Department of Health 1991; Indian Council of Medical 
Research, 2009). IAtta is in line with TFR concept as a complete sustainable, 
socially acceptable, food secure meal for malnourished advanced cancer patients. 
  
3.9.3 Food safety precautions concerning IAtta  
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3.9.3.1 Elimination of physical & biological contamination 
 
Gram, barley, soybean and linseeds were first sieved, then physically sorted to 
remove physical contaminants, roasted to eliminate anti-nutrients and minimize 
micro-organism growth and then powdered. Thereafter stored in air tight plastic 
labelled containers, on a raised platform in the food storage room (Figure 3.9-2).  
Amaranth spinosus leaves were washed twice in potable water to remove excess 
dirt then vacuum freeze dried and stored in nitrogen gas filled sealed packs (of 1Kg 
each) to maintain product integrity. All ingredients included were in roasted and 
dried form to ensure longer shelf life.  
3.9.3.1 IAtta dry mixing and packaging in septic environment 
  
IAtta packs were prepared in the hospital kitchen every evening before the patients’ 
appointment the next day. Utensils used during preparation and ingredient mixing 
were properly washed and disinfected before every use. Kitchen surface in contact 
with food was cleaned at initiation and adequate personal hygiene was ensured at 
all stages of IAtta preparation (figure 3.9-3). It was double packed using food grade 
plastic bags to eliminate moisture and pathogens. Each pack was labelled with use 
by date and batch number (figure 3.9-4). The caregiver was advised to discard left-
over IAtta at the end of the day. Caregivers were counselled to transport the packs 
carefully, store it away from direct sunlight, protect from pathogens and moisture to 
avoid contamination making it safe for patient consumption. 
 
 
Figure 3.9-2: Storage area for ingredients required for IAtta 
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Figure 3.9-3: Preparation of IAtta 
 
Figure 3.9-4: Packed IAtta 100g (dry weight) food label of packed IAtta showing 
ingredients, batch number, expiry date and nutritional information 
 
Nutrition Intervention in Indian Cancer   Chapter 3 
57 
3.9.4 IAtta sensory assessment  
 
Sensory evaluation for IAtta was done among twenty UoW students in the Nutrition 
laboratory. Three different combination formulations of IAtta (100g) were prepared 
by adding 20 g of sugar and 150 ml of cold water. The glasses containing the three 
formulations were labelled with three different coloured stickers and presented with 
a spoon to the students. Formulation 1(393 kcal/100g) was coded with an orange 
sticker, formulation 2 (396 kcal/100g) was coded with a green sticker and 
formulation 3 (398 kcal/100g) was coded with a blue sticker. A sensory evaluation 
form was distributed among them to complete (Appendix 13). Participants were 
asked to rate their formulation preferences on the hedonic scale and sip water in-
between sample tasting. In total, 88% of the respondents disliked all the 
formulations, 4% liked formulation 2 and 8% liked formulation 3. IAtta formulation 3 
was therefore finalised for the intervention but due to the low acceptance among the 
tasters it was decided to serve the formulation in a bread form. Unleavened flat 
breads (Chapattis, figure 3.9-5) were prepared by adding salt and spices and 
served to 8 UoW academic staff. All academics liked the chapatti and therefore it 
was decided that patients will be instructed to prepare fresh Chapattis from the IAtta 
pack.  
 
Patients undergoing cancer therapy frequently complain about changes in taste 
perception (Steinbach et al., 2009). Therefore, patients and their caregivers were 
advised to add spices and flavouring in the mixture while preparing IAtta chapattis. 
This leads to improvement in the appetite and meal acceptance level.  
3.9.5 IAtta cost-effectiveness  
 
To develop IAtta flour no sophisticated machinery or equipment was used. All the 
ingredients of IAtta are readily available in dried, roasted and powdered form in the 
local markets. Therefore, no prior complex treatment was required to prepare 
ingredients for the flour mixture. Household utensils like ladles, mixing bowl, kitchen 
scale and grinder were used to prepare the mixture before filling up 100g food-
grade plastic packets of IAtta flour for distribution among patients. The total cost to 
procure 100g of IAtta flour pack for one patient was as low as £0.20/day. 
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Figure 3.9-5: Packed IAtta and unleavened bread made from IAtta. 
 
3.10 Ethical Considerations 
 
The project was approved by ethics committee of UoW (App. no.: 12_13_11) and 
AIIMS (IEC/NP-79/2013; IEC/NP-339/08.10.2014, RP-17/2015). Permission was 
also obtained from ICMR (IF-25/13-NCD-III) and Indian Health Ministry before 
starting patient recruitment on the project. The project is registered under ICMR 
registry and Indian Health Ministry. The project is in compliance with the ethical 
requirements as laid down by the ICMR. Both trials are registered on 
www.clinicaltrials.gov vide, identifier no. NCT02350855 for pilot and NCT02561143 
for scale-up. 
 
Before enrolment, all participants were explained the purpose of the study, the 
procedures to be followed and the risks and benefits of participation. A unique 
patient code was used throughout the study in place of patient name in order to 
maintain confidentiality. The personal details and medical history information were 
stored at a secure place. Patient anonymity and project confidentiality was 
maintained throughout the project. Participation in the project was voluntary and 
directed towards their welfare. 
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Chapter 4: 
 
Results – Pilot Intervention  
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4.1 Introduction 
 
Out of the 63 patients recruited for the study, only 51% of the recruited patients 
completed the intervention. There were no demographic or clinical differences 
among the patients who dropped out compared to the ones who finished the study 
(detailed consort diagram as Appendix 14). The mean consumption of IAtta flour 
among the patients who ended the study after six months of intervention was 
45±11.26g/day. No side effects after consuming IAtta chapattis were reported by 
any patient. 
 
4.2 Baseline patient characteristics  
 
Patient baseline characteristics and tumour sites are included under Table 4.2-1 
and Table 4.2-2 respectively.   
Table 4.2-1: Baseline characteristics of all baseline patients 
 *Data presented as mean + SD or median (range)   
Baseline 
parameters 
Intervention group 
(n=30) 
Control group 
(n=33) 
p-value 
Anthropometric measurements 
Weight (Kg) 39.7 + 5.7 41.1+7.3 0.402 
BMI (Kg/m
2
) 17.6 +1.8 18.6 +2.5 0.077 
MUAC (cm) 20.8 +2.1 22.2 +2.4 0.49 
Body Fat (%) 20.5+5.2 25.4 +6.5 0.012* 
Nutritional assessment 
Energy intake 
(kcal) 
947.4 + 327.9 756.7 + 364.2 0.033* 
Protein intake (gm) 30.3+12.0 23.3 +12.6 0.03* 
Fat intake (gm) 28.1+13.1 24.9 +14.9 0.375 
PG-SGA score 7.8 + 2.2 9.4 + 2.6 0.010* 
Quality of Life Domains (Qualitative assessment) 
Global Health 
Status score  
66.7 (16.7,83.3) 50 (8.3,100) 0.026* 
Fatigue score  88.9 (0,100) 100 (0,100) 0.05* 
Appetite loss score  66.7 (0, 100) 100 (0, 100) 0.047* 
* In the table * denotes significant difference (p≤0.05). 
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Table 4.2-2: Tumour site for the recruited study patients 
Site of Tumour Intervention Group Control Group 
Ano-rectum 3 2 
Bone 1 2 
Brain 0 1 
Breast 7 7 
Buccal cavity 1 1 
Chest wall 1 1 
Eyelid 0 1 
Female genitourinary tract 12 10 
Lung 2 4 
Olfactory 1 0 
Spine 1 0 
Supra renal mass 0 1 
Thyroid 1 3 
 
4.3 Anthropometric measurements 
 
4.3.1 Anthropometric results  
Patients in the intervention group have shown increase in body weight but this was 
not statistically significant (p=0.081), while patients in the control group had shown 
statistically significant reduced body weight (p=0.003) and MUAC (p=0.006) at the 
end of the study period (6 months) (Figure 4.3-1 and 4.3-2). Body fat (p=0.002) 
increased significantly in the intervention group patients and decreased significantly 
(p=0.032) in the control group (Figure 4.3-3). Total body water content was 
comparable between patient groups at baseline, mid-intervention, and post-
intervention (p=0.453, p=0.234, and p= 0.727, respectively) (Appendix 15, Kapoor 
et al., 2016). 
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Adjusted analysis concluded significant difference in patients’ percentage body fat 
among the groups (p value 0.001). 
 
 
 
 
 
 
Figure 4.3-1: The bar graph depicts the body weights of patients during baseline, mid-
intervention and post intervention.  
 
 
 
 
 
 
 
 (n=30)  (n=21)   (n=17)      
 
           (n=33)   (n=18)    (n=15)      
 
p=0.081 p=0.003* 
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Figure 4.3-2: The graph shows MUAC of both group patients at different time points 
i.e. during baseline, mid-intervention and post intervention.  
 
 
 
 
 
 
 
 
 
 (n=30)  (n=21)   (n=17)      
 
           (n=33)   (n=18)    (n=15)      
 
p=0.346 p=0.002* 
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Figure 4.3-3: The graph shows change in % BF between the groups at baseline, mid-
intervention and post intervention.  
 
4.4 Dietary intake and nutritional status 
 
At the end of six months significant increase in macronutrients intake i.e. energy 
(p=0.001), carbohydrate (p=0.001), protein (p=0.001), fat (p=0.006) was observed 
in the patients eating IAtta assessed using two days 24 hour dietary recall. Using 
FFQ intervention group patients also showed statistically significant increase in 
energy (p= 0.006) intake. There was no statistical difference in the PG-SGA score 
among both the groups during the study period. Baseline parameters on adjustment 
showed that there was a significant change in energy intake (p= 0.004, by dietary 
    (n=30)  (n=21)   (n=17)      
 
        (n=33)  (n=18)  (n=15)      
 
p=0.032* 
p=0.002* 
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recall) and PG-SGA score (p<0.001) during intervention (Appendix 15, Kapoor et 
al., 2016). 
 
4.5 Physical Activity Assessment 
 
Physical activity recall showed significantly reduced activity (p= 0.004) among the 
control patients after 6 months of start of the study, while the intervention group of 
patients maintained (p=0.274) their physical activity levels throughout the study 
(Appendix 15, Kapoor et al., 2016). 
 
4.6 Quality of Life Parameters 
 
Patients eating IAtta showed significant improvement in certain domains of quality 
of life like fatigue (p=0.002) and appetite loss (p=0.006). A significant decrease in 
quality of life domains of global health status (p=0.018) and social functioning (p= 
0.004) was observed among control group patients. Both the groups reported 
significant improvement in pain [(p=0.012) in intervention group and (p=0.029) in 
control group].   
 
On adjusting global health status and fatigue score at baseline, a significant 
difference in these parameters was seen during the intervention at three months 
and six months’ time points (p <0.001) (Appendix 15, Kapoor et al., 2016). 
 
4.7 Biochemical Parameters Results 
 
Among the employed biochemical indicators, haemoglobin (IAtta group p=0.368 and 
control group p=0.819) and serum albumin (only control group p=0.368 available), 
no statistically significant differences were observed within the control and 
intervention groups or between them. 
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4.8 Discussion 
 
In the pilot study, IAtta meal supplementation along with nutritional counselling in 
advanced cancer female patients receiving palliative care improved their quality of 
life and stabilised body weight.  
 
Patients consuming IAtta for the duration of six months showed clinically increased 
body weight (increase in body weight by 2.5%) (p=0.081) and body fat percentage 
(increased by 3.7%) (p=0.002) in contrast to the control group who showed 
significant reduced body weight (decreased by 8.71%) (p=0.003) and body fat 
percentage (decreased by 5.2%) (p=0.032). The increase in body fat would be 
desirable in cachectic patients to support high BMR due to disease progression 
(Young et al., 1977; Dhanpal et al., 2011). Also, in this study, patients among the 
control group had reduction of 14.4% of MUAC (p=0.002) at six months as 
compared to baseline.  
 
The energy intake of all study patients at baseline was lower than the Indian adult 
female RDA (1900kcal/d) (Indian Council of Medical Research, 2010). There was 
no significant (p=0.735) change in the PG-SGA score of the intervention group 
patients at the end of intervention, which is similar to the pattern observed earlier in 
advanced colorectal cancer patients receiving ONS supplementation (Read et al., 
2007). 
 
In advanced lung cancer patients, it has been suggested that exercise and nutrition 
intervention may have a positive impact on un-intentional weight loss and physical 
function (Payne et al., 2013). The current study results are in line with the above 
studies, as patients eating IAtta maintained their body weight as well as physical 
activity levels. Also patients losing body weight (control group) showed reduced 
physical activity levels (baseline 30.7+2.7MET’s and at six months 28.0+2.5 MET’s) 
at the end of the study period. 
 
Observations in malnourished cancer patients suggests decline in quality of life with 
body weight loss (Wallengren et al., 2013; Thoresen et al., 2012). A similar trend 
was observed in this study, patients eating IAtta exhibited improvement in fatigue 
(p=0.002) and appetite loss (p=0.006) domains while weight losing control group 
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patients declined under the global health status (p=0.018) and social functioning 
(p=0.004) domains. 
 
4.9 Rationale for progression to scale-up study 
 
Comprehensive nutritional support guidelines are currently absent in palliative care 
framework for cancer patients in India. The findings of this pilot study underpinned 
the pivotal role of nutrition intervention in palliative care management. Some 
employed parameters showed a positive trend, however these can be translated 
into significant improvement of body weight and quality of life when IAtta has been 
consumed for a longer period of time and applied to a larger sample. Therefore, 
these results qualify for a wider intervention study in adult female cancer patients. 
This will also help to understand the impact of IAtta in sustaining patients’ daily 
lifestyle. Nonetheless, IAtta is a bio-available product and in-line with the Indian 
populations vegetarian food habit along with easy ingredient availability, it qualifies 
for an in-depth study on a wider population of cancer patients.  
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Results – Scale-up intervention  
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5.1 Introduction 
 
One hundred and fifty patients were recruited for the study, only 39% of the 
recruited patients finished the intervention. There were no demographic or clinical 
differences among the patients who dropped out compared to the ones who finished 
the study (detailed consort diagram as Appendix 16). The mean consumption of 
IAtta flour and whole wheat flour (as Chapattis) among the patients who finished the 
study after six months of intervention was 45.4 ± 11.7g/day and 40.9 ± 18.1g/day 
respectively. No side effects after consuming IAtta or whole wheat flour chapattis 
were reported by any patient. 
 
5.2 Baseline patient characteristics 
 
Patient baseline characteristics and tumour sites are included under Table 5.2-1 
and Table 5.2-2 respectively.   
 
Table 5.2-1: Baseline characteristics of study patients  
*Data presented as mean + SD or median (range)   
Baseline 
parameters 
Intervention group 
(n=75) 
Control group 
(n=75) 
p-value 
Anthropometric parameters 
Body weight (Kg) 43.3 ± 7.0 42.6 ± 7.1 0.589 
BMI (Kg/m2) 18.81 ± 2.82 18.86 ± 3.20 0.929 
MUAC (cm) 22.12 ± 2.72 21.93 ± 2.71 0.677 
Body Fat (%) 26.42 ± 5.68 26.65 ± 6.46 0.822 
Physical activity assessment 
Physical activity 
(MET’s) 
29.67 ± 3.13 28.52 ± 2.03 0.013 
Nutritional assessment 
Energy intake (kcal) 768.11 ± 372 688.66 ± 408.75 0.215 
Protein intake (gm) 26.06 ± 14.38 21.90 ± 13.31 0.068 
Fat intake (gm) 24.94 ± 17.28 24.38 ± 20.27 0.857 
PG-SGA score 8.92 ± 1.96 9.25 ± 1.74 0.272 
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Quality of Life Domains (Qualitative assessment) 
Global Health Status 
score 
29.23 ± 19.44 
 
28.44 ± 19.04 0.804 
Fatigue score  92.44 ± 14.86 92.74 ± 15.34 0.904 
Appetite loss score 83.55 ± 29.19 86.67 ± 26.85 0.500 
 
Table 5.2-2: Tumour site for the recruited scale –up study patients 
Site of Tumour 
Intervention 
Group 
Control Group 
Ano-rectum 8 3 
Bone 2 6 
Endocrine 7 7 
Breast 15 10 
Head & Neck 10 6 
Female genitourinary tract 18 17 
Lung 8 13 
Other 7 13 
Total 75 75 
 
The baseline characteristics among both patient groups were similar for all key 
indicators. The p-value was non-significant (p ≤0.05) for all anthropometric 
parameters, physical activity, dietary intake and quality of life domains when 
assessed at baseline.  
 
Most of recruited patients were receiving chemotherapy and/or radiotherapy at our 
institute during intervention. Few patients were post-operative when they were 
recruited (Figure 5.2-1).    
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Figure 5.2-1: Therapy received by scale-up patients who finished 6 months 
intervention. 
 
5.3 Anthropometric measurements 
 
Per-protocol analysis (IAtta group n= 29, placebo group n=30) 
Patients in the intervention group (IAtta group) have shown decrease in body weight 
43.3±7.0 Kg to 41.6±5.7 Kg (p=0.014), BMI 19.2±2.8Kg/m2 to 18.4±2.4Kg/m2 
(p=0.015) (figure 5.3-1), total body water (p=0.53) (figure 5.3-2) and MUAC 
(p=0.068) (figure 5.3-3), were maintained. However, patients in the control group 
(Placebo group) have shown significant increase in BMI (from 18.8±3.0Kg/m2 to 
19.2±3.3 Kg/m2, p=0.001) and total body water (p<0.001). MUAC was maintained in 
placebo group as well after 6 months of flour consumption. Body fat percentage 
reduction was observed in both the groups at 6 months, IAtta group 26.1±5.7% to 
24.9±4.8% (p=0.019) and Placebo group 25.3±6.9% to 23.2±7.9% (p=0.058).  
 
ITT analysis (IAtta group n= 75, placebo group n=75) 
According to ITT analysis, body weight (IAtta, p-value 0.111; Placebo, p-value 0.63) 
and BMI (IAtta, p-value 0.121; Placebo, p-value 0.35) was maintained in both the 
study groups at the end of intervention. MUAC (IAtta, p-value 0.007; Placebo, p-
value 0.001) and body fat percentage (IAtta, p-value <0.001; Placebo, p-value 
0.001) reduced significantly in both patient groups after 6 months of intervention. 
Body water percentage was maintained among IAtta patients (55.6±6.2% to 
56±8.2%, p=0.374) and a significant increase was observed among control group 
patients (54±6.2% to 55.9±6.1%, p<0.001). 
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Figure 5.3-1: The graph depicts BMI of patients at baseline, mid-intervention, and 
post-intervention. 
* Data presented as mean ± SD; P value ≤.05 was considered statistically 
significant.  
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Figure 5.3-2: The graph shows TBW of patients at baseline, mid-intervention, and 
post-intervention. 
* Data presented as mean ± SD; P value ≤.05 was considered statistically 
significant.  
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Figure 5.3-3: The graph depicts MUAC of patients at baseline, mid-intervention, and 
post-intervention. 
* Data presented as mean ± SD; P value ≤.05 was considered statistically 
significant.  
  
5.4 Dietary Intake  
 
Patients in both groups reported significant improvement (p<0.001) in their PG-SGA 
score by the end of intervention according to per protocol as well as ITT analysis. 
Both group patients maintained their PG-SGA level as moderately malnourished 
according to per-protocol analysis (IAtta p=0.226, Placebo p=0.923) as well as ITT 
(IAtta p=0.174, Placebo p=0.284).  
 
Per-protocol analysis (IAtta group n= 29, placebo group n=30) 
According to dietary data collected using two day recall and FFQ, IAtta group 
patients who finished the intervention reported significant improvement (p<0.05) in 
macro-nutrient intake after six months. Patients in placebo group (n=30) maintained 
(p>0.05) their energy, protein, fat intake at the end of intervention by employing two 
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day recall as well as FFQ. Placebo consuming patients reported significant increase 
in carbohydrate intake [105.2g (12.8, 270.2) to 114.7g (31.8, 261.0), p=0.039].  
 
ITT analysis (IAtta group n= 75, placebo group n=75) 
ITT analysis showed in IAtta group of patients, using two day dietary recall, 
documented significant increase in energy [677.1kcal (239.8, 2007.1) to 779kcal 
(239.8, 2521.5), p=0.032], carbohydrate [103.5g (19.8, 255.8) to 115.9g (26.8, 
255.8), p=0.015] and fat [21.7g (4.5, 100.5) to 27.8g (4.5, 108.2), p=0.011] after six 
months of intervention. Protein intake was maintained in both groups of patients 
(IAtta p=0.089, Placebo p=0.082) by two day dietary recall. Placebo group reported 
increase in energy [579.4kcal (148.3, 2155) to 692.4kcal (175.1, 1968), p=0.05] and 
fat [17.7g (0.33, 99.3) to 23.6g (1.1, 99.7) p=0.001] intake after six months of 
intervention by two day dietary recall. According to FFQ, IAtta patients maintained 
their energy (p=0.1) and protein (p=0.135) intake while their fat consumption 
increased significantly (p=0.024). Placebo group patients maintained (p>0.05) their 
nutrient intake throughout the intervention (by FFQ analysis). Even though placebo 
patients maintained their protein intake (p=0.082), at the end of six months 
intervention they reported significant increase in their body water percentage 
(p<0.001).  
 
5.5 Physical activity assessment  
 
Analysis using per protocol as well as ITT concluded that IAtta group had significant 
increase in their physical activity after 6 months of intervention (p<0.001 and p= 
0.001 respectively). According to per protocol analysis, patients consuming IAtta 
increased their MET’s from 30.3 ±3.4 (at baseline) to 31.2 ± 3.7 (after six months). 
 
Placebo group patients maintained their physical activity throughout intervention 
according to per protocol analysis (p=0.49) and ITT (p=0.955) (Figure 5.5-1). 
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Figure 5.5-1: The graph shows physical activity of patients at baseline, mid-
intervention, and post-intervention.  
* Data presented as mean ± SD; P value ≤.05 was considered statistically 
significant.  
 
5.6 Quality of life parameters  
 
Per-protocol analysis (IAtta group n= 29, placebo group n=30) 
Per protocol analysis reported that IAtta patients improved (p≤0.05) their global 
health status, fatigue, pain and nausea and vomiting by the end of intervention. 
Appetite improvement was noted in both group of patients (IAtta p<0.001, Placebo 
p=0.026). Placebo group patients maintained their global health status [37.5(0, 75) 
to 41.6(0, 83.3), p=0.74], fatigue [100 (33.3, 100) to 88.7 (55.6, 100) p=0.07], pain 
(p=0.64) and nausea and vomiting (p=0.25) throughout the intervention time. Both 
group patients reported significant reduction in social functioning after six months of 
intervention [IAtta (50(0,100) to 0 (0,100)) p=0.001, Placebo (50(0,100) to 4.67 
(0,100)) p=0.041]. Physical functioning was maintained in both group of patients 
(IAtta p=0.343, Placebo p=0.683) during the intervention period . 
 
ITT analysis (IAtta group n=75, placebo group n=75) 
ITT analysis results were in line with the per-protocol results as discussed above . 
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5.7 Biochemical Indices  
 
Per-protocol analysis (IAtta group n= 29, placebo group n=30) 
Placebo group patients reported significant decrease (p=0.029) in their serum 
albumin levels between baseline (4.1±0.5g%) and three month follow-up 
(3.9±0.4g%), while by the end of intervention the serum albumin levels were 
4.0±0.5g% (p=0.059, overall). Serum albumin levels were maintained (p=0.877) 
throughout intervention for the IAtta group patients. Haemoglobin levels (IAtta 
p=0.1, Placebo p=0.46) were maintained throughout study in both groups. 
 
ITT analysis (IAtta group n= 75, placebo group n=75) 
According to ITT analysis also, haemoglobin levels (IAtta p=0.664, Placebo 
p=0.141) were maintained throughout the study in both groups. Serum albumin 
levels were significantly reduced (4.0 ± 0.7g% to 3.8 ± 0.7g%, p=0.005) in placebo 
group patients after six months of intervention . 
 
C-Reactive protein (CRP) 
CRP levels were analysed in sub-group patients from intervention group (n=14) and 
placebo group (n=17). CRP levels were clinically increased among placebo group 
patients [from 5.4mg/L (0.9, 98) to 13.6mg/L (1.4,154), p = 0.097] and decreased 
among IAtta patients [7.7mg/L (0.4,43.4) to 6.75 mg/L (0.9,66.9), p = 0.177] after six 
months of intervention ). 
 
Modified Glasgow prognostic score (mGPS) was calculated using serum CRP 
levels and serum albumin in sub-group patients from intervention group (n=14) and 
placebo group (n=17). Patients who had both a serum elevation of CRP (>10 mg/L) 
and hypoalbuminemia (<3.5 g/dL) were allocated a GPS of 2. Patients with only one 
of the abnormal values were allocated a GPS of 1, and patients who had neither 
were allocated a GPS of 0 (Figure 5.7-1 and 5.7-2).  
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Figure 5.7-1: Intervention group patients categorised according to their respective 
mGPS at baseline and post-intervention time-points 
 
 
 
 
 
 
Figure 5.7-2: Placebo group patients categorised according to their respective mGPS 
at baseline and post-intervention time-points 
 
After six months of intervention there was no significant difference in mGPS within 
groups when assessed at baseline and after six months of intervention (IAtta: 
0.57±0.76 versus 0.64±0.84, p=0.765; Placebo: 0.47±0.62 versus 0.82±0.81, 
p=0.112). 
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5.8 Discussion 
 
In the current study, IAtta meal supplementation along with nutritional counselling 
resulted in improved physical activity and quality of life compared to patients 
consuming whole wheat flour.  
 
Results were analysed using per protocol as well as ITT method. ITT gives a 
pragmatic approach to trial results. It is a conservative form of analysis as it 
considers noncompliance patients leading to dilution of treatment effect. According 
to a review comparing various guidelines, ITT principle should be employed while 
analysing trial results. ITT analysis should be viewed as the primary test and per 
protocol as a supporting test. Treatment effect is considered profound when both 
types of analysis are in line (Gupta, 2011). According to ITT and per protocol 
analysis, body water increased significantly (p<0.001) after six months intervention 
in placebo group patients while it was maintained (p=0.374) in IAtta group. Similarly 
physical activity was significantly (p=0.001) improved in IAtta patients after six 
months of intervention along with improved domains (health status, fatigue and 
appetite; p<0.001) of QoL. Serum albumin levels as well were significantly reduced 
(p=0.005) in placebo group at the end of intervention. These results signify the 
superiority of IAtta compared to whole wheat flour routine intake among cachectic 
cancer patients. 
 
Cachexia is a multi-factorial syndrome and is often associated with oedema in 
patients (VanCutsem and Arends, 2005). BIA is a non-invasive and user friendly 
body composition technique. BIA has been validated among advanced cancer 
patients for estimation of TBW (Davis et al., 2009). A recent review concluded that 
using the same BIA equipment under controlled conditions repeatedly for TBW 
measurement is valid among incurable cancer patients (Haverkort et al., 2015).  
 
Anti-cancer treatment among advanced cancer patients frequently leads to 
anaemia. Patients undergoing repeated intensive chemotherapy sessions suffer 
from higher anaemia risk (Rodger et al., 2012). Baseline assessment depicted most 
of the patients were receiving anti-cancer therapy and were anaemic (Hb<12g/dl). 
The reduced haemoglobin levels were maintained in both the groups (IAtta, 
p=0.664; Placebo, p=0.141) throughout the intervention. One of the main reasons 
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that we did not notice any impact of IAtta on haemoglobin levels of patients could be 
regular blood transfusion in all cancer patients prior to planned therapy sessions. 
 
Albumin forms about 50% of the total blood proteins. Albumin modulates colloidal 
osmotic pressure and determines intravascular volume. More than 50% of albumin 
is present in the extravascular region. Serum albumin depicts long term protein 
status with a half-life of 14 to 20 days. Presence of oedema is often a symptom of 
low serum albumin concentration. Reduction in albumin levels is commonly 
observed in cancer, hepatic failure, zinc deficiency, inflammation, nephritic 
syndrome, trauma and burns. Inflammation state (in cancer) leads to reduction in 
albumin levels as body prioritises production of acute phase proteins and limits 
production of other body proteins. Presence of weight-loss and muscle wasting in 
patients can be overlooked due to oedema (Donna, 2012; p 257). IAtta group 
patients, however did not report oedema, this could be explained on the basis of 
maintained blood serum albumin throughout the intervention. Malignancies result in 
a variety of pathological changes resulting in adverse effects on the normal 
homeostatic processes. In addition to the treatment modalities and their side 
effects, the malignant process also contributes to the disruption of the physiological 
processes. The control of extracellular fluid is influenced by various proteins, 
sensors, hormones and organs (Fazzari and Singh, 2016; p 85). In malignancies 
apart from the decreased serum albumin levels leading to extravascular fluid 
increase, other factors also play a role. These are mainly due to inflammation 
affecting the vascular endothelial barrier and leading to increased permeability. The 
presence of oedema is multi-factorial and is related to the tumour, serum protein 
levels and the chronic inflammatory state (Fazzari and Singh, 2016; p 85-88). 
 
Body fluid is present in three main compartments namely the capillaries, lymphatic 
and the interstitium, in addition to the veins and arteries. The interstitial space is 
made up of interstitial fluid and extracellular matrix. There is interplay of dynamics 
depending on signalling molecules affecting the collagen and glycosoaminoglycans 
which is present in a gel like phase. This allows the interstitium to take in water. 
Physiologically, the amount of water depends on the permeability of the capillary 
endothelium. Pathologic processes in the form of colloid osmotic pressure changes 
or factors affecting capillary permeability lead to an increase in the amount of water 
in the interstitium. Capillary permeability is impacted by various cytokines and 
cytotoxins in various malignancies leading to an increase in amount of interstitial 
Nutrition Intervention in Indian Cancer   Chapter 5 
81 
fluids. Reduced colloid osmotic pressure also causes increase in interstitial fluid. 
This colloid osmotic pressure depends on the albumin level and hypoalbuminemia 
leads to increased interstitial fluid. Increased interstitial fluid is clinically seen as 
oedema. Oedema is therefore seen in malignancies due to the interplay of 
cytokines, cytotoxins and hypoalbuminemia (Fazzari and Singh, 2016; p 85-88). 
 
Our results indicate that there is no significant difference in the body weight (IAtta 
group p=0.111, Placebo group p=0.63) of two groups after six months of 
intervention. However, when we studied the TBW by BIA in both the groups we 
noticed that the placebo group showed a higher TBW (baseline 54±6.2% versus 
post-intervention 55.9±6.9%, p=0.001). Albumin levels in both the groups revealed 
that the placebo group (baseline 4.0±0.7g% versus post-intervention 3.8±0.7g%, 
p=0.005) had significantly lower levels compared to baseline. This lead to the 
probable conclusion that the body weight maintenance in the placebo group (p= 
0.63) was a function of water retention rather than improvement in other parameters 
(muscle mass and body fat). The IAtta group had better albumin levels (baseline 
4.0±0.7g% versus post-intervention 3.9±0.7g%, p=0.239) compared to the other 
group. Hence it may be concluded that the non-significant difference in weight is 
because of the poor nutritional status as indicated by serum albumin levels and 
resultant water retention in the form of clinical oedema. Other underlined factors 
may also be responsible for oedema among these patients, which requires in-depth 
research for better understanding. IAtta patients were anaemic throughout the 
intervention period; however they did not report oedema.  
 
To our knowledge this is the first study to report oedema in cachexic cancer patients 
with significant reduction in serum albumin levels after six months of consumption of 
whole wheat flour. 
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6.1 Introduction  
 
The main aim of the study was to delay progression of cachexia to refractory 
cachexia in female cancer patients by providing nutritional support as a part of the 
palliative care system. Patients suffering from cancer cachexia experience 
increased protein catabolism leading to loss of lean body mass, which is irreversible 
by nutritional support (Fearon et al., 2011). Our objective was to stabilize and 
improve nutritional status of our study population. Once patients enter the stage of 
refractory cachexia they fail to respond to anti-cancer therapy and their survival time 
is less than three months (Fearon et al., 2011). 
 
The discussion is subdivided into five main categories: 
 
6.2 Anthropometric measurements 
6.3 Dietary intake and nutritional status 
6.4 Physical activity  
6.5 Quality of life parameters 
6.6 Biochemical indicators 
6.7 Limitations 
 
6.2 Anthropometric measurements  
 
In the pilot study (n=63), control group patients showed a mean body weight loss of 
8.71% and scale-up study (n=150) placebo patients maintained their body weight 
(p=0.263) at the end of intervention (6-month period). Patients in IAtta group 
maintained their body weight after six months of intervention in both the studies. 
TBW was also measured in both the study groups. During pilot study, TBW content 
was comparable between patient groups at baseline, mid-intervention (3-month), 
and post-intervention (p=0.453, p= 0.234, and p=0.727, respectively). In scale-up 
study (n=150), only the placebo group reported significant increase of 9.8% in their 
TBW (p<0.005). In placebo group the key reason for higher TBW (baseline 54±6.2% 
versus 55.9±6.1%) could be reduction in plasma albumin levels (baseline 
4.0±0.7g% versus 3.8±0.7g%) leading to disturbance in the water distribution 
between blood and tissues.  
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Placebo group patients’ diet was supplemented with plain whole wheat flour 
whereas the IAtta group was consuming the specially formulated flour mix with high 
protein content (26g/100g). Analysis (ITT) of the dietary protein intake during scale-
up study did not show any significant difference within the groups after six months 
of intervention. Comparison of the protein intake between the groups after six 
months supplementation was however statistically significant (p=0.01). This 
indicates that the intervention group consuming IAtta had better dietary protein 
intake (IAtta included soybean which is a good source of protein consisting all 
essential amino acids). Furthermore, this was reflected and corroborated by 
stabilized serum albumin in IAtta group patients (baseline 4.0±0.7g% to post–
intervention 3.9 ± 0.7g%, p=0.239) and placebo group patients reported significant 
reduction in albumin levels (baseline 4.0±0.7g% to post–intervention 3.8±0.7g%, 
p=0.005) (similar to phenomenon reported by Gupta and Lis (2010)). Serum 
albumin levels influence the total body water through a process of water retention. 
The reduced albumin levels in the placebo group influenced the body weight 
through water retention (figure 6.2-1). 
 
 
Figure 6.2-1: Cascade phenomenon observed among scale-up cachexic female 
patients during intervention (adapted from Fazzari and Singh, 2016; p 93).  
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An increase in body fat percentage (baseline 20.5± 5.2% versus post-intervention 
23.7 ± 5.3%, p=0.002) was noticed among the small number of IAtta consuming 
patients however the same trend was not seen (baseline 26.1± 5.7% versus post-
intervention 24.9 ± 4.8%, p=0.019) in the scale-up study. Significant difference was 
observed in MUAC between the groups in the pilot study (IAtta group p=0.346 and 
in control group reduction, p=0.002) while the same parameter declined significantly 
in both the groups in the scale-up study (IAtta group, p = 0.007 and placebo group, 
p=0.001).   
 
As regards body weight, there was no improvement in nutritional status of cancer 
patients who are at nutritional risk even after significant increase in energy and 
protein intake for three months of intervention. This has been reported in an earlier 
study (Uster et al., 2013). In this study patients, in nutrition therapy group reported 
stable performance status compared to patients under usual hospital care. In the 
same RCT, Uster and colleagues (2013) noticed that patients with higher albumin at 
the end of intervention had better muscle strength (hand- grip strength). Our results 
are in-line with Uster et al., (2013) as patients did not gain body weight during 
intervention and reported physical activity maintenance and/or increase compared 
to controls. In addition to this, IAtta patients reporting higher albumin levels (3.9 ± 
0.7g% versus placebo 3.8 ± 0.7g% post-intervention) also continued with their daily 
activity and reported better health status (QoL). Body weight maintenance (p=0.479) 
was also reported among cachexic patients with mixed tumour cancers receiving 
ONS (Prosure and Ensure plus) for two months (Dewey et al., 2015). Cancer 
patients (mixed tumour site) receiving chemotherapy and/or radiotherapy were 
randomized into either nutrition therapy group (ONS with dietary counselling 
dietician) or usual care group (counselling by staff nurse) for up to three months by 
Poulsen et al., (2014). No significant difference in body weight, body fat, TBW and 
muscle mass was noticed between the groups even though the therapy group 
reported significant increased protein intake at the end compared to usual care 
group. In the present scale- up study, no significant difference in body weight, body 
fat and muscle mass between groups was evidenced even though significant 
(p=0.01between groups after six months of IAtta/placebo supplementation) 
increased protein intake in IAtta consuming patients was reported. Poulsen and 
colleagues (2014), enrolled patients receiving anti-cancer therapy with palliative as 
well as curative intent. Protein intake at baseline by patients in both the groups was 
higher (46-89g/d) than our study patients (IAtta 26±14.4g/d and placebo 
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21.9±13.3g/d). The above mentioned reasons (mixed treatment population and 
protein intake) could be the main factor for their study patients to report no changes 
in serum albumin and TBW levels. One of the main limitations from Poulsen et al., 
(2014) study was the values for muscle mass, body fat and TBW at baseline and 
post-intervention were not stated for comparison review. The intervention period in 
our study was six months compared to three months in the Poulsen et al., (2014) 
study. The presence of oedema in our placebo study group could be the result of 
increase in inflammatory levels (clinical increase in CRP and mGPS, section 5.7). 
Weight maintenance (p=0.412) has been observed in advanced oesophageal 
cancer patients receiving anti-cancer therapy, on tailored nutrition intervention 
program along with maintained serum albumin levels (p=1.00) on completion of 
planned radiotherapy (Cong et al., 2015). Control patients under physician care 
reported significant weight loss (p<0.001) and reduction in serum albumin (p ≤ 
0.001) (Cong et al., 2015), these results are in line with our trial results. 
          
The progressive significant reduction in body fat (assessed using SFT) and muscle 
mass (assessed by MUAC) in both group of patients observed during scale-up 
study is due to extended catabolic phase experienced by cachectic patients.  
Tumour progression leads to disruption in protein synthesis and degradation cycle 
in order to retain muscle mass. Fat tissue depletion during cachexia is a common 
feature which further leads to skeletal muscle depletion (Porporato et al., 2016). 
Intervention initiated in cachectic patients in their early phase of disease can lead to 
muscle gain (Prado et al., 2013). CT imaging observations among advanced cancer 
patients has shown progressive muscle reduction from 9 months until death (Prado 
et al., 2013). Most cancer patients in India are diagnosed in their advanced stage of 
cancer due to limited healthcare access (Goss et al., 2014). Basal metabolic rate, 
individual tumour site, response to anti-cancer treatment and catabolism level could 
be the main contributory factors for the patients not maintaining their body muscle 
level. Per-protocol analysis for IAtta scale-up concluded MUAC maintenance in both 
the groups. Therefore, the impact of IAtta on muscle mass maintenance was 
noticed; however as per statistical ITT analysis it was not significant (p=0.007). 
Another fact is that the patients during the study could not consume the entire 
(100g) dietary supplement (IAtta) provided. IAtta (per pack 100g) would have given 
them additional 25g of protein. As per observation the average protein intake was 
less than 30g/d (among IAtta scale-up patients). Keeping in view the high catabolic 
demands during malignant conditions it is likely that higher protein intake may have 
significant beneficial effect on nutritional status and cachexia progression.  
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6.3 Dietary intake and nutritional status 
 
Research has shown that disease progression in malignancy leads to increase in 
BMR (Young et al., 1977; Dhanpal et al., 2011). Therefore, the energy intake of 
patients should be higher to maintain their nutritional status. The energy intake of all 
study patients at baseline was lower than the Indian adult female RDA (<1900 kcal, 
Table 4.2-1 and 5.2-1). IAtta (each pack 100g/day) would give three flat breads (on 
average) providing approximately 400 kcal. The mean consumption of IAtta flour 
among the patients who finished the study after six months of intervention was 45.4 
± 11.7g/day. Scale-up study patients receiving IAtta or placebo reported a 
significant increase (compared to baseline) in their daily energy, protein (only IAtta 
group) and fat intake at the end of the intervention, which was greater than their 
average consumption (Section 5.4). The key reason could be nutritional counselling 
imparted at each visit (one visit every fortnight) as well as during telephonic follow-
ups. Studies have reported significant improvement among advance cancer 
patients’ nutritional status with nutritional counselling (Baldwin and Weekes, 2012; 
Balstad et al., 2014; Silvers et al., 2014; Lee et al., 2016). According to Ravasco 
and colleagues (2012), nutritional counselling improves PG-SGA scores in 
advanced colorectal patients which could have helped both group study patients 
(IAtta, p<0.001 and placebo, p<0.001 during scale-up) to significantly improve their 
respective malnutrition scores after six months of intervention. According to ICMR 
(2010), 1.0g/Kg/d of protein is recommended for Indian adults. Literature review 
suggests weight maintenance in advanced cancer patients can be achieved by 
1.5g/Kg/d of protein intake (Bauer and Capra, 2005; Senesse et al., 2014). Each 
IAtta pack provides 50% of their daily protein requirement (Table 3.9-1). Therefore, 
at post-intervention, both studies’ IAtta patients reported significant increase in 
protein intake which could have helped them in maintaining and/or increasing their 
physical activity significantly. These dietetic consumption observations are in line 
with Sánchez-Lara et al., (2014) RCT on advanced lung cancer patients. In Lara’s 
study (2014), the control group patients were prescribed a diet based on their 
energy requirements while the study group patients were given Prosure ONS for 
consumption during cancer therapy. Prosure group patients reported weight 
maintenance as well as improvement in health status, appetite and fatigue (QoL 
domains), similar to our study observations. In our study, despite progression of the 
neoplastic disease, positive impact on patient health status could be the cumulative 
positive effect of IAtta natural ingredients. 
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6.4 Physical activity and functionality  
 
In advanced lung cancer patients, it has been suggested that exercise and nutrition 
intervention may have a positive impact on un-intentional weight loss and physical 
function (Payne et al., 2013). A statistically significant positive correlation has been 
concluded between physical activity and quality of life (Oechsle et al., 2011). 
 
A group of 80 advanced cancer patients enrolled into a two month palliative 
rehabilitation program (involving dietitians, physiotherapist, doctors and social 
workers) in order to correct their dietary intake and improve physical activity 
(Feldstain et al., 2016). In this study, patients reported improvement in their physical 
activity level (p<0.001) and depression score (p<0.002). These results are in line 
with our study results, as in both studies patients consuming IAtta either reported 
maintenance (p=0.274) or improvement (p=0.001) in their physical activity. Palliative 
cancer patients attending gym sessions along with dietician and physician 
counselling have reported significant improvement in physical activity as well as 
symptom severity (Chasen et al., 2013). These results are in accordance with our 
observations. IAtta patients reported increased activity (p=0.001) along with 
improvement in their appetite, fatigue, nausea and vomiting and constipation 
(section 5.6). Though both the groups received physical activity counselling in our 
study, the key factor for improved physical activity in the intervention group could be 
consumption of nutrient rich IAtta, partially compensating the protein and 
micronutrient deficit in their diets. Weight-losing advanced cancer patients with 
lower MUAC have reported reduced functional abilities (functional ability was 
defined as walking on the treadmill) (Wallengren et al., 2013). A similar trend was 
observed among control weight losing patients during our pilot study, who reported 
reduced physical activity levels at the end of the study period (p=0.004, Appendix 
15, Kapoor et al., 2016 ). 
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6.5 Quality of life parameters 
 
Maintenance of cancer patients’ nutritional status has been emphasised in ESPEN 
European Society of Clinical Nutrition and Metabolism and Nutrition in Cancer 
patients Guidelines. According to these guidelines, treatment goals should be 
centred towards symptom management (from disease progress and anti-cancer 
therapy) and improvement of QoL (Arends et al., 2006; Arends et al., 2016). A 
recent meta-analysis studied the impact of nutrition intervention (ONS and/or 
counselling) on QoL using EORTC C-30 questionnaire (Baldwin et al., 2015). On 
comparison with usual patient care, nutrition intervention had a significant positive 
impact on emotional functioning, appetite, dyspnoea and global health status 
(Baldwin et al., 2015). QoL domains of appetite, dyspnoea and global health status 
(p<0.001, p=0.047 and p<0.001 respectively) significantly improved in patients 
consuming IAtta for six months. In line with the ESPEN guidelines, significant 
symptom improvement like fatigue, pain, constipation and nausea–vomiting 
(p<0.001, p=0.047, p=0.007 and p<0.001respectively) was also observed in the 
IAtta patients compared to placebo group.  
 
Advanced lung cancer patients (on palliative chemotherapy) consuming ONS 
(Prosure) were compared with control patients on standardized diets according to 
their calorie requirements. Patients consuming ONS maintained their body weight 
with increased macronutrient intake and significant decrease in CRP levels after six 
months of intervention (Sánchez-Lara et al., 2014). Both group of patients reported 
albumin level maintenance throughout the study. Similar to our intervention group 
patients, significant QoL improvements were reported for domains global health 
status, fatigue and appetite. Compared to Sánchez-Lara and colleagues (2014) 
RCT, the key reason for not observing a significant difference in CRP levels could 
be the small number of samples assessed (due to unavailability of investigations in 
the same unit). CRF has been reported by 99% of cancer patients from diagnosis to 
end of life. A review on lung cancer survivors reported CRF as a limiting factor in 
patients’ daily activities and their QoL (Paramanandam et al., 2015). They 
concluded that exercise can help in management of CRF in lung cancer patients 
(Paramanandam and Dunn, 2015). Our study patients consuming IAtta were able to 
increase their physical activity (baseline 29.6±3.1MET versus post-intervention 
30±3.3 MET’s, p=0.001) by the end of intervention and reported significant 
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improvement in their fatigue levels (p<0.001) when assessed using EORTC C- 30 
QoL questionnaire.   
6.6 Biochemical indicators 
 
Haemoglobin and serum albumin were assessed in both groups of the study. One 
of the main reasons that we did not notice any impact of IAtta on haemoglobin 
levels (baseline 9.6±1.7 g/dl versus post-intervention 9.6±1.7 g/dl, p=0.664) of 
patients could be regular blood transfusion in all cancer patients prior to 
chemotherapy. All patients recruited in the study were anaemic (Hb<12g/dl) and in 
order to be eligible for chemotherapy, patients undergo blood transfusion regularly 
to raise their haemoglobin levels. Serum albumin levels were significantly lower 
among placebo group patients (baseline 4.0 ± 0.7 g% versus post-intervention 3.8 ± 
0.7 g%, p=0.005) during the scale-up study while the IAtta patients (baseline 4.0 ± 
0.7 g/dl versus post-intervention 3.9 ± 0.7 g/dl, p=0.239) had maintained their levels 
after six months of intervention. Malnourished head and neck cancer patients, who 
were prescribed a dietary plan according to their East Indian food habits, reported 
significant improvement in their protein status along with increase in serum albumin 
levels (Bhattacharjee et al., 2015).  
 
CRP levels were assessed (baseline and at six months) among few patients of both 
the group during the scale-up study. There was no significant difference between as 
well as within (p>0.005) the groups after six months of intervention. However, in the 
placebo group patients a greater clinical increase in CRP levels (baseline 5.4mg/L 
versus post-intervention 13.6mg/L, p=0.097) was observed after the intervention 
compared to the IAtta patients. This is an indicator of ongoing inflammatory activity 
on the placebo group patients (Suzuki et al., 2013, see section pathophysiology of 
cancer cachexia section 2.3). Nevertheless, the intervention group has shown 
maintenance in CRP levels (baseline 7.7mg/L versus post-intervention 6.75mg/L, 
p=0.177) along with significant improvement in QoL (global health status domain, 
p<0.001) after six months of intervention. ONS containing n-3 fatty acids was 
offered to advance lung cancer patients for five weeks supplementation while the 
controls were given isocaloric ONS. The intervention group patients had better 
weight maintenance as well as fat free mass, but no difference in CRP levels was 
observed between groups (van der Meij,et al., 2010). Recent RCT on palliative 
oncology patients undergoing a rehabilitation program reported significant 
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improvement (p<0.001) in physical activity but CRP levels did not significanctly 
improve (Feldstain et al., 2016). These results are similar to our study as even 
though our IAtta patients maintained their body weight (p=0.111), CRP level was not 
significantly (p=0.177) different compared to placebo patients (p=0.097). 
 
The modified Glasgow prognostic score (mGPS) is a combined indicator for 
malnutrition and systemic inflammation (McMillan, 2013). Among placebo group 
patients, mGPS assessment at baseline and post-intervention showed that score 
had increased by 3.5% while in the IAtta group patients it had increased by just 
0.7% (section 5.7). Higher GPS score is associated with reduced survival and is 
superior to predicting survival compared to markers like white blood cells, platelets 
and neutrophil count (Polterauer et al., 2010). Increased mGPS has been 
associated with body weight loss, dietary intake, co-morbidities, poor performance 
status and treatment complication (McMillan, 2013). A similar trend was observed in 
our study, where placebo group patients even though receiving treatment for 
symptom management reported no significant improvement in pain, fatigue, 
constipation, appetite, dyspnoea, nausea and vomiting (QoL domains).  
 
6.7 Overall discussion   
 
Literature review (Table 2.8-1) has shown very few ONS intervention RCT among 
advanced cancer continuing follow-up more than three months. One of the 
uniqueness of this project was the six month follow-up duration of the intervention 
for all participating patients. 
 
On comparison of the employed parameters between IAtta and whole wheat flour 
consuming patients, we can conclude that IAtta patients performed better after six 
months of intervention compared to the placebo patients. In the table 6.7-1below, 
scale-up study parameter results analysed using ITT has been compared. CRP and 
mGPS results mentioned were analysed for a few patients using per protocol 
method.    
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Table 6.7-1: Comparison of primary and secondary parameters between IAtta and 
Placebo patients. 
Parameter IAtta Placebo 
Body weight Maintained 
(B: 42.1 ± 7.2; A: 41.5 ± 7.1) 
Maintained 
(B: 42.7 ± 7.3; A: 42.9 ± 7.9) 
MUAC Significant reduction 
(p = 0.007) 
Significant reduction 
(p = 0.001) 
Body fat Significant reduction 
(p < 0.001) 
Significant reduction 
(p = 0.001) 
Total body water Maintained 
(B: 55.6 ± 6.2; A: 56 ± 8.2) 
Significant increase 
(p<0.001) 
Dietary protein 
intake 
Maintained 
(B: 22.6 (5.6, 67.9); 
 A: 29.1 (5.7, 86.2)) 
Maintained 
(B: 19.7 (3.2, 66);  
A: 20.8 (3.2, 70.5)) 
PG-SGA score Significant improvement  
(p < 0.001) 
Significant improvement  
(p < 0.001) 
Physical activity Significant improvement 
(p = 0.001) 
Maintained 
(B: 28.5 ± 2; A: 28.6 ± 0.3) 
QoL Global 
health status 
Significant improvement 
(p <0.001) 
Maintained 
(B: 25 (0, 75); A: 25 (0, 83.3)) 
QoL Fatigue Significant improvement 
(p <0.001) 
Maintained 
(B: 100 (33.3, 100);  
A: 100 (33.3, 100)) 
QoL Appetite 
loss 
Significant improvement 
(p <0.001) 
Maintained 
(B: 100 (0, 100);  
A: 100 (0, 100)) 
Serum albumin Maintained 
(B: 4.0 ± 0.7; A: 3.9 ± 0.7) 
Significant reduction 
(p = 0.005) 
CRP Maintained 
(B: 7.7 (0.4, 43.4);  
A: 6.75 (0.9, 66.9)) 
Maintained 
(B: 5.4 (0.9, 98);  
A: 13.6 (1.4, 154)) 
mGPS Maintained 
(B: 0.6 ± 0.8; A: 0.6 ± 0.8) 
Maintained 
(B: 0.5 ± 0.6; A: 0.8 ± 0.8) 
* ‘B’ denotes baseline values and ‘A’ denotes post six months intervention values.  
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6.8 IAtta comparison with commercial products 
 
Post pilot study, home visit for a patient consuming IAtta was implemented. Informal 
talks with the caregiver and family members gave us an understanding regarding 
perception of IAtta. The caregiver informed the investigator that any leftover of IAtta 
meal was discarded by end of the day. Patient would not share their IAtta meal with 
other family members as they consider it a part of their daily medication.  
 
Prosure, Ensure, Resource and Fresubin are ONS mostly prescribed by 
oncologists. The most important factor in commercial ONS intake is limited 
availability in rural India and its cost. Among the products prescribed, Prosure 
contains fish oil and therefore makes it unacceptable for the vegetarian Indian 
population. Commercial ONS’s are sweet in taste and therefore acceptance is 
limited among patients suffering from therapy related taste alterations (Table 6.8-1).   
 
Patients are overloaded with advanced cancer treatment expenses hence they find 
it difficult to spend for ONS. Commercial ONS is consequently not a sustainable 
option. With IAtta, patients can avail additional nutrition as per their taste 
preferences (salty or sweet), while being an indigenous part of their dietary pattern. 
IAtta consists of local grains, pulses and oilseeds ingredients available at all grocery 
shops throughout the year. Amaranth spinosus grows throughout India as a weed 
and is easily accessible (Kumar et al., 2010) (Figure 6.8-1). 
Table 6.8-1: IAtta comparison with commercial products 
 
Characteristics  IAtta 
(Recommended 100g/day)   
Commercial ONS 
(Recommended two serves per day, one 
serve = 200-250ml) 
Vegetarianism    ×  
Synthetic Ingredients  ×    
Natural ingredients    ×  
Affordability    
(£0.2/100g/day)  
× 
(£1.75-2.3/100g)  
Sustainability    ×  
Part of Indian staple 
diet  
  ×  
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FAO’s approach for combating hunger involves sustainable agricultural and rural 
development helping direct access to food for the malnourished (affected people). 
According to FAO, “Food security exists when all people, at all times, have physical 
and economic access to sufficient, safe and nutritious food that meets their dietary 
needs and food preferences for an active and healthy life” (World Food Summit, 
1996).  
 
Agriculture is the main source of income for more than half of the Indian population, 
supporting the largest poor population. It contributes to about 14% of Indian GDP. 
India produces over 260 million tonnes of food grains, 269 million tonnes of 
agriculture produce and 132 million tonnes of milk (Food Agriculture Organisation, 
2016). Majority (83%) of the agricultural land is possessed by farmers in form of 
small holding (under 2 hectares of land), leading to limited profit from production 
and becoming most affected from climate change. Rainfall (unequal and /or 
inadequate), temperature variation and natural disasters affect agriculture produce, 
threatening food security. These scenarios affect the small landowners living in rural 
India. Keeping all this into consideration, the IAtta formulation was done in such a 
manner; that the ingredients will be available all over the year not being affected by 
monsoon fluctuation. 
 
IAtta can be set up as an innovative model of a nutrition-sensitive intervention in 
accordance with world food programme mission and Food Agriculture Organisation 
approach to combat undernutrition among advanced cancer patients. 
 
Palliative care framework for cancer patients in India lacks nutritional support 
guidelines. From the above results it is evidenced that nutrition plays a pivotal role 
in palliative care management. 
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Figure 6.8-1: Multi-dimensional advantages of tailored food recipe - IAtta  
 
6.9 Limitations 
  
There were a number of limitations observed during the current study and they are 
listed below: 
 
6.9.1 Anorexia and loss of appetite  
The key reported causes for low intake of IAtta was anorexia and appetite loss 
which is commonly observed in cancer cachexia patients.  
 
6.9.2 Gastrointestinal tract complication 
Constipation due to medication (morphine to control cancer pain) and vomiting as 
well as mucositis mostly due to chemo-radiotherapy were some of the main 
reasons. This would lead to the inability to eat the prescribed amount of IAtta. 
Treating Palliative Physician prescribe stimulant laxative and stool softener to the 
patients. Most patients were unable to afford the medication from pharmacy and 
therefore suffered from severe constipation throughout intervention. Constipation 
among these patients was associated to abdominal discomfort, poor appetite, 
impaired nutritional status and interruptions of scheduled anti-cancer treatment.    
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6.9.3 Drop-out 
High patient drop out during intervention was due to co-morbid conditions causing 
life-threatening complications and long waiting time for anti-cancer therapy 
sessions. Attrition rate as high as 44% has been reported in palliative oncology 
studies because of clinical deterioration and mortality among patients (Hui et al., 
2013; Visser et al., 2015). Recruiting patients at an early stage of the disease would 
help in reduction of the attrition rate among palliative patients. Till date there is no 
biomarker for classification of patients in refractory cachexia stage. Therefore, few 
drop-out patients could have been in their refractory cachexia stage during 
recruitment of the intervention. 
 
6.9.4 Financial barrier 
Socio-economic compulsions in the form of financial inadequacy also leads to 
inability of the patient to receive cancer treatment. Caregivers were unable to pay 
for their fare tickets to reach the hospital. Generic prescription drugs were available 
free of cost to patients at the hospital. However, as all drugs are not supplied by the 
hospital and specific drugs were required for symptomatic management of the side-
effects. The patients could not afford to procure the same from the market and this 
led to various conditions like constipation, nausea, vomiting and muscositis 
impacting intake of prescribed supplement (IAtta).     
 
6.9.5 Appropriateness of used field tool 
Tanita segmental body composition machine was used during the study to assess 
the body fat percentage and muscle mass of the patients. CT imaging or DEXA are 
considered more accurate tools to identify muscle wasting (Del Fabbro, 2015). As 
access to regular CT imaging or DEXA was not available, estimation of muscle 
mass (variable) was excluded from the study.  
 
6.9.6 Biochemical assessment availability 
Laboratory facility to analyse CRP levels was not available in the oncology 
department at AIIMS, New Delhi. Patients had to get their blood samples to a 
different department at AIIMS for CRP analysis. Due to this inconvenience, only few 
patients could get their CRP levels analysed during the scale-up study. 
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7.1 Author’s critique 
 
During the study, a high patient drop-out rate was experienced. On telephonic 
conversation with the patient it was understood that financial constraints, travelling 
long distances for treatment and stay at lodging house arrangements with 
compromised hygienic conditions were the key reasons for low follow up in cancer 
care. Gender inequality is commonly observed in many parts of the Indian society. 
The patriarchal approach, where men are the decision makers for the family, leads 
to female health issues being frequently neglected. Many female patients were 
unable to attend follow-up sessions at AIIMS due to their domestic chores and 
house responsibility.   
 
CT imaging, MRI and DEXA facility (for muscle mass determination) is available at 
AIIMS. However, due to lack of equipment availability, scans are done once in eight 
to twelve months or on severe symptom complaints. Though, there has been a 
sharp increase in cancer patients in India, the infrastructure at hospitals is still not 
well developed to support optimal treatment. If patients undergo imaging in their 
early stages of diagnosis, treatment can be planned timely. Also regular scans will 
aid in monitoring disease progression. Most patients have to wait at least three to 
four months for a scan appointment (except X-ray) at AIIMS after oncologist referral. 
This leads to further delay in starting palliative chemoradiotherapy or planning 
surgery, impacting patients QoL.  
 
Dietary restrictions laid by family members, superstitions, complementary medicine 
practitioners and religious healers were barriers faced during nutritional counselling 
sessions. Family caregivers (mostly children, mother or siblings) used to try and 
force feed the patient causing distress. Lack of knowledge among caregivers 
regarding disease prognosis and cachexia symptoms was an issue that too needed 
attention during counselling sessions. Caregivers often suffer from depression like 
symptoms and altered dietary practices leading to more eating related distress than 
the patient herself. Telephonic counselling session was imparted to all patients 
weekly during the intervention and helped in building a healthy relationship with 
them. These weekly sessions also gave a better understanding about their dietary 
patterns and might have contributed to better and/or maintenance of QoL. Studies 
in the past have reported improved nutritional status and QoL in cancer patients 
receiving telephonic counselling by dieticians (Silvers et al., 2014).  
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CRP is the most widely accepted inflammation marker for cancer cachexia 
assessment by western clinical bodies (Suzuki et al., 2013). In India where high 
percentages of cancer patients are diagnosed at late stages cachexia prevalence 
should be high (though undocumented). CRP analysis is still not a routine test at the 
oncology department and our study patients had to pay for the same in a different 
department.      
 
The most important factor in commercial ONS intake was limited availability in rural 
India and financial constrains. Taste acceptance was also a factor contributing 
towards low compliance of commercial ONS. Patients would always correlate 
commercial ONS with medicines which have side-effects. Their main fear was the 
well-being of their family on accidental consumption of the same. IAtta was made 
using natural vegetarian ingredients which they could consume while in company of 
other family members accompanied by their daily food preparations. The low 
compliance during our study was mainly due to treatment side-effects and co-
morbidities. 
 
7.2 Conclusion 
 
Embedding nutrition supplementation within the palliative care therapy is likely to 
improve quality of life and stabilise heath status in cancer cachexia patients 
receiving anti-cancer therapy. Maintenance of inflammatory status among IAtta 
consuming patients meets the objective of the proposed study. These positive 
findings qualify IAtta for extensive intervention and to ascertain its position within 
palliative care framework in India. 
 
ONS available in the market contain synthetic products with limited bioavailability 
and not affordable by the low socioeconomic status patients. To our knowledge this 
is the first study to show that a combination of readily available (sustainable) food 
products can aid in body weight maintenance of palliative free living cancer patients. 
This study results indicate that if readily bio-available (natural) nutritional 
supplementation (like IAtta) is offered to cancer cachexia female patients their 
health status can be maintained along with increased physical activity and they may 
experience improvement in some aspects of quality of life.  
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7.3 Future work 
 
A recent systematic review on interventions among cancer cachexic patients (Cuhls 
et al., 2016), concluded that mineral, vitamin, protein and other types of 
supplementation had limited effect. Dietary supplementation on the other hand had 
no adverse effect and therefore impact of food supplementation should be further 
studied among cachexic palliative cancer patients (Cuhls et al., 2016).     
 
We propose the following suggestions for future work:  
 Effect of IAtta consumption on cancer specific sites can be assessed and 
validated. 
 Inclusion of a team of nutritionist/dietician amongst doctors and health 
professionals in Pain and Palliative Care OPD will be proposed at AIIMS 
hospital. 
 Nutritional guidelines and food recipes to be drafted for Indian cancer 
cachexia patients and shared with health authorities. 
 Sustainability plan: Workshops and training sessions to be arranged for 
cancer patients receiving palliative care at different health centers in New 
Delhi to create awareness regarding effectiveness of nutritional intervention 
in palliative cancer patients. Patients will be empowered to prepare their own 
meal. They will be guided about ingredient procurement, storage, mode of 
preparation, cooking, discarding leftover and maintain food hygiene. 
Caregivers will be included in these sessions to educate them about the 
disease symptoms and best patient management protocol.   
 Rural and tertiary care centres will be approached for an extension of IAtta 
intervention study. 
 NGO’s providing patient home visit should be educated about importance of 
good nutrition in cancer palliative care.  
 Workshops and training sessions to be organised for doctors, nurses and 
health care workers, to educate them regarding the nutritive value of natural 
food ingredients that can be incorporated in diets of palliative cancer 
patients. The nutritive value of super foods consumed commonly by the 
patients to be highlighted in these sessions in order to deliver better 
nutritional counselling. 
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8.2 Appendices 
 
Appendix 1: Patient information sheet 
 
To assess the effectiveness of tailored food recipe in delaying the 
progression of cachexia to refractory cachexia in adult female cancer 
patients: A study based in India. 
 
We would like to invite you to participate in this research study. Please read the 
following details regarding the study and your involvement carefully before you 
decide to take part. If you require further clarification or have additional questions 
contact us. 
 
What is the purpose of the study? 
Cancer cachexia is a complex disorder marked by progressive weight loss 
(wasting), in association with anorexia (loss of appetite), asthenia (lack of energy 
and strength) and altered immune function. Weight loss may be prevented and 
quality of life may improve by supplementing the patient’s diet with energy and 
protein dense food along with physical activity. Therefore the main aim of this study 
is to delay the progression of cancer cachexia to refractory cachexia, by nutrition 
intervention program among free living female patients. 
  
Can I take part in the study? 
Yes if you are: 
Female, age 18 years and above. 
Not pregnant woman or a nursing mother 
Suffering from cancer with no gastrointestinal tract defects affecting nutrient 
digestion and absorption. 
Have weight loss more than 5% from pre-treatment weight or Body Mass Index less 
than 20Kg/m2. 
Haemoglobin level less than 12g/dl. 
Energy intake less than 1500kcal/d (to be assessed on consultation). 
 
What is expected from me? 
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You will be asked to sign a “consent form” and a copy of the “information sheet” will 
be provided. We will seek your permission to access your past medical records. 
Physical measurements will be taken and you will be expected to complete certain 
questionnaires regarding your well-being. Depending upon the group you are 
randomly assigned to, you might be asked to consume the prepared supplement 
once a day for duration of 6 months along with nutritional and physical activity 
counselling.  
 
What types of measurements / tests will be performed on me? 
On the first day of the study following measurements will be taken: 
Weight 
Height 
Mid-upper arm circumference 
Skin fold thickness 
This involves measurement of thickness of a vertical fold on the right upper 
arm, shoulder blade and waist using a Skinfold Caliper. 
A series of questionnaires will be completed to provide information regarding 
your well-being and medical history. 
All the above mentioned measurements will be repeated at the end of 3 months and 
6 months of participation. Your haemoglobin levels will be monitored by referring to 
regular hospital medical test reports.  
 
How can I prepare the “IAtta” Chapatti? 
A sealed packet will be provided for each day of the study period. The packet will 
contain roasted horse gram, barley flour, soybean flour, amaranth spinosus and flax 
seeds in dry powdered form. Please follow the steps below to prepare the Chapatti: 
Empty the contents of the packet in a mixing bowl.  
Add some water, salt and spices according to your taste. 
Gradually knead the dough and add some more water until soft to make 
balls.  
Using the roller make chapattis and heat them on the pan until cooked.  
Apply some ghee or butter on top, if required. 
Are there any risks of taking part in the study? 
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There are no risks involved in the study. The ingredients used for IAtta composition 
are natural vegetarian food items and commonly consumed by the community. All 
the physical measurements taken are non-invasive. 
 
How will confidentiality be maintained throughout the study? 
A unique patient code will be used throughout the study in place of patient name in 
order to maintain confidentiality. The personal details and medical history 
information will be stored at a secure place.  
 
What are the advantages of taking part in the study? 
The counselling sessions organized for all patients taking part in the study may help 
to improve your quality of life. If you are randomly assigned in the intervention group 
you will be consuming the iAtta chapatti which may help you to gain weight or 
stabilize weight loss and respond optimally to chemotherapy (and other forms of 
treatment). 
 
What is the procedure to withdraw from the study? 
If you decide not to be a part of the study, you are free to withdraw at any time. Your 
participation in the study is completely voluntary. On withdrawal all your records will 
be erased and you will be asked to return the unused IAtta powder packets to the 
investigator. 
 
How will the results be used after the study? 
The results would be interpreted and written by the investigator and will be used for 
research output (but individuals will not be identified). The research output will be 
available to you upon your written request. If you wish to read a copy of the final 
report please contact the researcher.  
 
What should I do next to take part in the study?  
Please fill in the “consent form” and contact me to arrange for an appointment.  
 
Please note that the decision to participate in this study should be your own 
and choosing not to take part will not disadvantage you in any way. 
 
For any further questions or information please contact me: 
Neha Kapoor: n.kapoor@my.westminster.ac.uk 
  
Nutrition Intervention in Indian Cancer  Chapter 8 
121 
 
  
Nutrition Intervention in Indian Cancer  Chapter 8 
122 
 
 
 
 
Nutrition Intervention in Indian Cancer  Chapter 8 
123 
 
  
Nutrition Intervention in Indian Cancer  Chapter 8 
124 
 
  आई. ए.   .   . ए.                              ? 
  
                       ए                         ए                 आ 
      आ  ,       आ       आ   ,            आ  ,       आ                
औ                 आ                                               ए 
              ए                    
 ए                               
                      ए            
                     -       ई       ए                     ए    
   औ                                      
                           ए ए                              
          ए   
 
                       ई         ? 
 
                                  आई. ए.   .   . ए.            ए      
                                               ए   ए  
       :                                                   ई     
                              आ                 ,  ई      ,     ,       
             ए     औ                    ए                           
 
                                       ए  ?  
 
               ए          ए                                   ए  
                               ए                  ए                     
ए                     ए     
Nutrition Intervention in Indian Cancer  Chapter 8 
125 
 
  
Nutrition Intervention in Indian Cancer  Chapter 8 
126 
 
Appendix 2: Patient informed consent form 
PARTICIPANT INFORMED CONSENT FORM   
Protocol / Study number:_ IEC/NP-79/2013  
Participant identification number for this trial:  
Title of project: To assess the effectiveness of tailored food recipe in delaying the 
progression of cachexia to refractory cachexia in adult female cancer patients: A study 
based in India 
 Name of Principal Investigator: Miss Neha Kapoor                Tel. No(s). 09958282099  
The contents of the information sheet dated…….that was provided have been read 
carefully by me / explained in detail to me, in a language that I comprehend, and I have 
fully understood the contents. I confirm that I have had the opportunity to ask questions. 
The nature and purpose of the study and its potential risks / benefits and expected 
duration of the study, and other relevant details of the study have been explained to me in 
detail. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal right being affected. 
I understand that the information collected about me from my participation in this 
research and sections of any of my medical notes may be looked at by responsible 
individuals from AIIMS. I give permission for these individuals to have access to my records. 
I agree to take part in the above study. 
---------------------------------------------     Date: 
(Signatures / Left Thumb Impression)    Place: 
Name of the Participant: ____________________________________  
Son / Daughter / Spouse of:__________________________________  
Complete postal address: _____________________________________  
This is to certify that the above consent has been obtained in my presence. 
------------------------------  
Signatures of the Principal Investigator     Date:  Place:  
1) Witness – 1      2) Witness – 2 
------------------------------      --------------------------------  
Signatures       Signatures  
Name:       Name:  
Address:       Address:  
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सहभागी सचुित सहमतत प्रपत्र 
इस जाचं के लिए सहभागी पहचान नमबर IEC/NP-79/2013 _______________ 
अनुसन्धान शीर्षक: महहिा कैं सर रोगगयों में आग रोक दबुषिता को दबुषिता की प्रगतत में देरी में पोर्ण 
हस्तक्षेप के प्रभाव का अध्ययन करन ेके लिए भारत में आधाररत एक अध्ययन 
 
मुख्य अन्वेर्क का नाम ____ नेहा कपूर_____  फोन नंबर: 0091-9958282099 
 
मैंने हदनांक_______________ के सचूना पत्र में हदये गए सभी तथ्यो को पड़ लिया 
हैं| मझु ेसमझ आने वािी ंभार्ा मैं ववस्तारपवूषक बत्ता हदया है और मनैें तथ्यो को भिी 
भांतत समझ लिया है| मैं पषु्टि करता हूूँ कक मझुे प्रशन पछुने का अवसर हदया गया 
है| 
मझुे अध्ययन की प्रकृतत, उद्देश्य और इसके सम्भाववत िाभ/जोखिमों और अध्ययन की 
सम्भाववत अवगध अन्य प्रासगंगक जानकारी के बारे में ववस्तार पवुषक समझा हदया गया है 
| में समझाता हूूँ कक इस अध्ययन में मेरी भागगधारी स्वेतछक है और इस अध्ययन से 
ककसी भी समय बबना कोई कारण बताए, बबना मेरी गचककत्सा देिभाि या काननूी 
अगधकारों के प्रभाववत हए अपना नाम वावपस िे सकता/सकती हूूँ | 
मैं समझता हूूँ कक इस अनसुन्धान में मेरी सहभागगता से मेरे बारे में एकत्र जानकारी 
और गचककत्सीय नोिों को एम्स अस्पताि के ष्जम्मेदार िोगो द्वारा देिा जायेगा| मैं 
इन व्यष्ततयों को अपने ररकोर्ष देिन ेकक अनमुतत प्रदान करता/करती हूूँ | 
मैं उपयतुतष अध्यन में भाग िेने के लिए अपनी सहमतत प्रदान करता /करती हूूँ | 
सहभागी के हस्ताक्षर / बाए ंअगंठेू का तनशान       हदनांक               
स्थान  
सहभागी का नाम  
वपता/पतत का नाम  
परूा पता  
यह प्रमाखणत ककया जाता हे कक उपयतुतष सहमतत मरेी उपस्थतत में िी गईं हैं | 
मखु्य अन्वेर्क के हस्ताक्षर                    हदनाक:        स्थान: 
१) गवाह के हस्ताक्षर      २) गवाह के हस्ताक्षर  
   नाम          नाम 
   पता          पता
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Appendix 3: Pilot study design 
 
 
 
 
Appendix 4: Nutritive value whole wheat flour  
(Gopalan et. al., 2012, p.47) 
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Appendix 5: Scale-up study design 
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Appendix 6: Questionnaire used during 
intervention 
 
 
 
Name:     Age:     Sex: 
 
UHID:      IRCH No:   
 
Address: 
 
Mobile: 
 
Weight (Kg):   Height (cm):    BMI (Kg/m2): 
 
Diagnosis:       Cancer Stage: 
 
History of treatement: 
 Radiotherapy: 
 Chemotherapy: 
 Previous Surgery (Describe): 
 
Biochemical Investigations: 
 Hemoglobin /PCV: 
 Albumin: 
 C-Reactive Protein: 
 
Anthropometry: 
 Baseline Follow-up 
Body weight (Kg)   
BMI (Kg/m2)   
Body fat(%)   
Total body water (%)   
Muscle Mass (Kg)   
Physique rating   
Bone mass (Kg)   
BMR(kcal)   
Metabolic age (yrs)   
Visceral fat level    
MUAC (cm)   
Skin fold thickness 
Bicep (mm)   
Tricep (mm)   
Suprascapular (mm)   
Suprailliac (mm)   
  
To evaluate the effectiveness of nutritional counselling and “Improved Atta” 
supplementation in delaying progression of cachexia to refractory cachexia in 
adult cancer patients in Indian population.  
 
Dr. Rakesh Garg Dr. BRAIRCH, AIIMS New Delhi. Mob: 9810394950 
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Appendix 7: Tools used for dietary recall 
portion size estimation 
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Appendix 8: Food frequency questionnaire  
* Permission received from Satija et al., (2012) to use the questionnaire for research 
purpose  
 
 
CEREALS 
Portion 
Size 
Average 
consumpt
-ion 
Per 
Day 
Per 
We-
ek 
Per 
Month 
Per 
Yea
r / 
Nev
er 
1.1 Tandoor roti, 
phulkas, Chapathis, 
parathas, naan 
No      
1.2 Stuffed parathas No      
1.3 Ragi roti No      
1.4 Bajra, maize roti No      
1.5 Jowar,  channa roti No      
1.6 Poori, bhatura No      
1.7 Plain rice Bowl      
1.8 Vegetable pulao/ 
veg biriyani 
Bowl      
1.9 Mutton, chicken 
pulao/biriyani 
Bowl      
1.10 Khichdi Bowl      
1.11 Idlis No      
1.12 Plain dosa, masala 
dosa, uthappam 
No      
1.13 Poha Bowl      
1.14 Dalia Bowl      
1.15 Oats porridge Bowl      
1.16 Corn flakes, cereal 
flakes etc. 
Bowl      
1.17 Bread, Toast, Rolls, 
Buns 
No      
1.18 Pizza, Burger No      
1.19 Noodles, macaroni, 
pasta etc 
Bowl 
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2.1 Plain tur dhal 
sambar / dhal   
Ladle      
2.2 Tur dhal sambar / 
dhal with vegetables 
Ladle      
2.3 Channa, rajma, dry 
peas etc. curry 
Ladle      
2.4 Green leafy 
vegetable curry 
Ladle      
2.5 Paneer gravy Ladle      
2.6 Kadhi Ladle      
2.7 Bengal gram dhal 
curry 
Ladle      
2.8 Blackgram dhal 
curry 
Ladle      
 CHUTNEYS / 
SALAD / PAPAD 
      
3.1 Soups, all types (veg 
or non-veg) 
Bowl      
3.2 Fresh vegetable 
salad 
Tbsp      
3.3 Vegetable Raitha Tbsp      
3.4 Mango, lime pickle 
etc.  
Tsp      
3.5 Papad  No      
3.6 Chutney  
(Tomato, Tamarind, 
Coriander, etc.) 
Tbsp      
 NON – 
VEGETARIAN 
      
4.1 Chicken curry Bowl      
4.2 Chicken fry/grilled No      
4.3 Mutton/ pork curry Bowl      
4.4 Mutton /pork fry No.      
4.5 Fish curry  Bowl      
4.6 Fish fry No      
4.7 Organ meats (Liver, Tbsp      
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brain, kidney etc.) 
4.8 Prawn, crab, shell 
fish etc.  
Bowl        
4.9 Egg (boiled, 
poached, omelettes) 
No      
4.10 Ham, salami, bacon 
etc. 
Slices      
 MILK & 
BEVERAGES 
      
5.1 Tea Glass      
5.2 Coffee Glass      
5.3 Plain milk Glass      
5.4 Flavored milk 
(horlicks, bournvita 
etc) 
Glass      
5.5 Curd, yoghurt Bowl      
5.6 Buttermilk/Lassi Glass       
5.7 Fresh fruit juice(lime, 
orange etc) 
Glass      
5.8 Fanta, pepsi, coca 
cola etc.  
250ml 
bottle  
     
5.9 Beer Glass      
5.10 Wine Glass       
5.11 Spirits (whiskey, gin, 
rum) 
30ml 
peg  
     
5.12 Aam ka panna Glass      
 MISCELLANEOUS        
6.1 Butter/ cream Tsp      
6.2 Ghee Tsp      
6.3 Jam Tsp      
6.4 Sugar Tsp 
 
     
6.5 Honey Tsp      
6.6 Jaggery Tsp      
6.7 Cheese Cube      
Nutrition Intervention in Indian Cancer  Chapter 8 
135 
6.8 Ketchup, tomato 
sauce 
Tbsp       
 SNACKS/ 
SWEETS/DESSERT
S 
      
7.1 Mixture, namkeen, 
chiwda, khara 
boondi, dalmoth 
Tbsp      
7.2 Nuts (grounduts, 
cashewnuts etc.) 
Tbsp      
7.3 Chips, French fries Bowl      
7.4 Samosa,bajji 
,bonda, cutlet, 
patties, puff 
No      
7.6 Biscuits (sweet, 
creamed, salted etc) 
No       
7.7 Bhel puri, masala 
puri, other chaats 
Bowl       
7.8 Dhokla No      
7.9 Pav bhaji No      
7.10 Cakes or sweet 
pastries 
No      
7.11  Payasam, kheer Bowl      
7.12 Custard, puddings Bowl       
7.13 Ice cream Bowl      
7.14 Jamoon, Jilebi, etc. No      
7.15 Ladoo, barfis No      
7.16 All Halwas Tbsp       
7.17 Shakarpara, 
balushahi, Gujiya 
 
No  
 
 
 
   
7.18 Indian milk sweet 
(peda, rasgulla etc. 
No      
7.19 Dairy milk, 5 star, 
kitkat etc. 
Chocolates 
 
Small 
Bar 
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FRUITS 
Porti-
on 
Size 
Average 
consumpt
-ion 
Pe
-r 
Da
-y 
Per 
Week 
Per 
Mo-
nth 
Per 
Year/ 
Never 
Sea
-
son
-al 
8.1 Banana No       
8.2 Apple  No       
8.3 Orange  No       
8.4 Sweet lime  No       
8.5 Mango  No       
8.6 Guava   No       
8.7 Grapes Bowl       
8.8 Pineapple  Slice       
8.9 Papaya Slice       
8.10 Pomegranate  No       
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Appendix 9: 24 hour dietary recall 
 
 
Questions 
 
 
Menu 
 
Ingredients 
 
Amount in 
household 
measure 
 
 
Consistency 
(Dry/Liquidy/  
Thick/Soft/NA) 
 
Final 
Weights (for 
investigators 
use only) 
 
Did you eat or 
drink anything 
after you got 
up in the 
morning 
yesterday? 
 
What did you 
have? 
 
     
 
Did you eat 
/drink anything 
else in the 
morning? (if 
working ,then 
specify; “before 
going for 
work”) 
 
What did you 
have? 
 
     
 
Did you 
eat/drink 
anything in the 
afternoon? 
 
What did you 
have? 
 
 
 
 
    
 
Did you eat/ 
drink in the 
evening (if 
working, then 
specify; “after 
coming from 
work”) 
 
What did you 
have? 
 
 
 
 
 
    
 
Did you 
eat/drink 
anything at 
night? 
 
What did you 
have? 
 
     
 
Did you eat or 
drink anything 
else just before 
going to bed? 
 
What did you 
have? 
 
     
 
Is there 
anything else 
that you 
ate/drank 
yesterday 
which you 
haven’t told me 
already? 
 
What did you 
have? 
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Appendix 10: PG-SGA questionnaire  
 
* Available for use in Bauer et al., (2006)  
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Appendix 11: Physical activity questionnaire  
 
* Permission received from Sullivan et al., (2012) to use the questionnaire for 
research purpose  
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Appendix 12: Quality of life  
 
* Permission received from Fayers et al., (2001) to use the questionnaire for 
research purpose  
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Appendix 13: Sensory evaluation questionnaire 
 
Food Product for evaluation: IAtta  
(100% natural ingredient: Roasted chickpea flour, roasted barley flour, 
roasted soybean flour, roasted flaxseeds powder & dried amaranth leaves 
powder)  
 
Please taste the presented formulated three samples and evaluate them 
according to following characteristics: Aroma, appearance, etc. See table 
below. 
Provide marks between 1 to 5, according to your liking.  
1 
Strongly 
disliked 
2 
Disliked 
3 
Acceptable 
4 
Liked 
5 
Most liked 
 
Characteristics Orange Blue Green 
Aroma    
Appearance    
Consistency 
/Thickness 
   
Texture    
Taste    
 
Please re-arrange the 3 
formula according to 
your taste preferences 
Formula Insert your preference 
here  
 
Orange  
Blue  
Green  
 
Comments (if any): 
......................................................................................................................................
......................................................................................................................................
......................................................................................................................................
......................................................................................................................................
.................................................... 
 
Thank you for your time.  
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Appendix 14: Consort flow diagram for pilot 
study 
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Appendix 15: IAtta pilot study results  
* Full text available for free access in Kapoor et al., (2016)  
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Appendix 16: Consort diagram for scale-up 
study 
 
 
 
